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Cancer treatment increases survivors risk for cardiorespiratory and cardiovascular 
diseases, alterations of body composition, and loss of muscular strength. Regular physical 
activity can be an effective strategy to reduce the risk of non-cancer related death among cancer 
survivors. Recently, high intensity functional training (HIFT) has been identified as an 
effective modality for improving fitness, body composition and muscle strength in cancer 
survivors. The primary aim of this study was to determine the effect of HIFT on 
cardiorespiratory fitness, cardiovascular health, physical function, and body composition in 
breast cancer survivors previously treated with chemotherapy and/or radiation therapy. It was 
hypothesised that high intensity functional training will be safe and effective at increasing 
fitness, body composition and strength in breast cancer survivors, with a null hypothesis of no 
change seen in these variables. The exercise intervention involved a 20-week HIFT program, 
utilizing a variety of exercise modalities, including aerobic (walking/running, rowing, cycling), 
resistance (machines, dumbbells, kettle bells) and body weight exercises (e.g. squats, push 
ups). Participants exercised twice weekly, with each session lasting approximately 30-minutes. 
The HIFT intervention sessions included 12 exercise stations, with participants exercising at 
each station for 2-minutes, before having 30-seconds to move to the next station. Physical 
function was measures through balance and functional tests, cardiorespiratory fitness assessed 
through V̇O2peak tests, strength tests through a variety of one-repetition max tests and body 
composition through BIA. Significant improvements were observed in lift and carry (p=0.17), 
weighted stair climb (p=.012), posterior leg reach (p=.014), thigh extension (p=.007) and 
flexion (p=.027) strength and systolic blood pressure (p=.012). Favourable, but non-significant 
(p>.05), effects on body composition were observed. No significant (p>0.05) change was seen 
in bench press 1RM, handgrip strength or V̇O2peak. This study showed that HIFT can provide 




current study were already physically active, which may account for the lack of change in upper 
body strength and cardiorespiratory fitness. No significant reductions were observed in any 
variable, suggesting that HIFT is effective at maintaining and, in some cases, improving aspects 
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Breast cancer is the most commonly diagnosed malignancy among females in New 
Zealand and is the third most commonly diagnosed cancer overall (Ministry of Health, 2016). 
Approximately 3300 women in New Zealand are diagnosed every year, close to nine women 
per day (Ministry of Health, 2017). Earlier diagnosis and improving methods of treatment are 
increasing survival rate among breast cancer patients (Kantarjian, Wolff, & Koller, 2011; 
Madan, Benson, Sharma, Julka, & Rath, 2015; Peel et al., 2009). Decreases in cancer-related 
mortality have increased the number of breast cancer survivors in the population. Improving 
rates of breast cancer survivorship is increasing the prevalence of long-term and late side-
effects of cancer treatment, with cardiovascular disease (CVD) progressively becoming a more 
common cause of death among breast cancer survivors. Breast cancer treatment including 
chemotherapy, radiotherapy and endocrine/hormonal treatment all carry an increased risk of 
cardiovascular and/or cardiorespiratory disease (Aleman et al., 2014; Armanious et al., 2018; 
Gernaat et al., 2017; Park et al., 2017; Patnaik, Byers, DiGuiseppi, Dabelea, & Denberg, 2011; 
Yu & Jones, 2016). 
 Cardiorespiratory and functional fitness are significant determinants of prognosis 
among breast cancer survivors, with an increase in both cardiorespiratory and functional fitness 
associated with a reduction in breast cancer mortality risk, recurrence risk and CVD (Adams 
et al., 2017; Gibala, Little, Macdonald, & Hawley, 2012; Lee, Artero, Sui, & Blair, 2010; 
McKenzie, 2012; Nystoriak & Bhatnagar, 2018; Peel et al., 2009; Stocci, De Feo, & Hood, 
2007). Treatment-induced lowering of cardiorespiratory and functional fitness negatively 
impacts survivorship (Harbeck, Ewer, De Laurentiis, Suter, & Ewer, 2011; Jette, Sidney, & 




 Structured exercise interventions are effective at increasing cardiorespiratory and 
functional fitness and reducing adverse side-effects of cancer treatment in breast cancer 
survivors. Aerobic, resistance and combined training are the most commonly prescribed 
training modalities for breast cancer survivors and their effects on the cardiorespiratory system 
are known. High-intensity functional training, a relatively novel modality known for its 
effectiveness among service populations, has begun to be implemented in clinical populations. 
High-intensity functional training incorporates the high-intensity aspect of high-intensity 
interval-training and the multi-planar, multi-modal movement patterns of functional training 
(Crawford, Drake, Carper, DeBlauw, & Heinrich, 2018; De Vreede, Samson, Van Meeteren, 
Duursma, & Verhaar, 2005; Heinrich et al., 2015; Heinrich, Patel, O’Neal, & Heinrich, 2014; 
Pacheco, Teixeria, Franchini, & Takito, 2013). 
 The purpose of this study was to investigate the effect of a 20-week high-intensity 
functional-training circuit on recreationally active breast cancer survivors functional and 
cardiorespiratory fitness, muscle strength and body composition. It was hypothesised that a 
high-intensity functional training program would improve these variables in already active 








Breast cancer treatment, while effective at increasing survival rate, is not without 
associated negative side-effects (Condorelli & Vaz-Luis, 2018; Joiner & Kogel, 2009; 
Kantarjian et al., 2011; Madan et al., 2015; Tao, Visvanathan, & Wolff, 2015). Negative effects 
can affect cardiorespiratory and cardiovascular systems, body composition and functional 
fitness (Armanious et al., 2018; Bradshaw et al., 2016; Demark-Wahnefried et al., 2001; 
Freedman et al., 2004; Gernaat et al., 2017; Hooning et al., 2007; Jones, Nestore, Henophy, 
Cousin, & Comtois, 2014; Klassen et al., 2014; Park et al., 2017; Peel et al., 2009; Raptopoulos 
& Constantinou, 2020; Yu & Jones, 2016). Exercise is safe and effective at reducing negative 
side-effects in breast cancer survivors (Anderson et al., 2012; Battaglini et al., 2007; Dolan et 
al., 2016; Kampshoff et al., 2015; Leach et al., 2019; Martin, Battaglini, & Naumann, 2015; 
Thomas et al., 2017). This chapter will review relevant literature exploring the effect of cancer 
treatment on physiological health, the effect of exercise on these negative side-effects, and 
methods of prescribing exercise to breast cancer survivors. 
Treatment of breast cancer 
 Breast cancer treatment involves a variety of treatment methods used either in isolation 
or combination. Treatment methods include chemotherapy, radiation, surgery, hormone 
therapy and endocrine therapy (Kantarjian et al., 2011). Several key factors influence the 
prescription of breast cancer treatment including the type and stage of the tumour, patients age, 
menopausal status, patients preferences (Kantarjian et al., 2011; Neal & Hoskin, 2009). 
Chemotherapy is considered a systemic treatment and is generally given intravenously, while 




undertaken in the neoadjuvant (pre-surgery) or adjuvant (post-surgery) setting (Kantarjian et 
al., 2011).  
Pre-surgery, both chemotherapy and radiation aim to either minimize or eliminate tumours. 
Post-surgery, their use aim is to destroy remaining malignant cells after tumour removal 
(Halperin, Perez, & Brady, 2008; Joiner & Kogel, 2009; Kantarjian et al., 2011; Neal & Hoskin, 
2009). Surgical treatment options are dependent on whether the cancer is localised 
(lumpectomy) or widespread (mastectomy). Hormonal treatments such as Trastuzumab 
(Herceptin) and Pertuzumab (Perjeta) are prescribed for the approximately 15-25% of breast 
cancers that have receptors for human epidermal growth factor-2 (HER-2) in the tissue sample, 
while Tamoxifen and aromatase inhibitors (AIs) are prescribed for those with estrogen receptor 
positive breast cancer (Kantarjian et al., 2011; Piccart-Gebhart et al., 2005; Sabel, Sondak, & 
Sussman, 2007). 
Chemotherapy 
Chemotherapy is a systemic treatment involving cytotoxic agents or monoclonal 
antibodies to kill cancer cells. The procedure can be used alone, or in combination with other 
treatments such as radiation, surgery and/or hormonal treatments (Brighton & Wood, 2005; 
Kantarjian et al., 2011; Neal & Hoskin, 2009; Tobias & Hochhauser, 2015). The administration 
of chemotherapy is usually intravenous infusion, but can be administered orally. Chemotherapy 
can be administered in the neoadjuvant or adjuvant setting (Kantarjian et al., 2011; Tobias & 
Hochhauser, 2015). Neoadjuvant chemotherapy is often used for high-grade or large tumours, 
HER2-positive breast cancer, triple-negative breast cancer, or cancer that has spread to lymph 
nodes (Kantarjian et al., 2011; Nahta & Esteva, 2006; Piccart-Gebhart et al., 2005). 
Chemotherapy use in the neoadjuvant setting can result in a reduction in tumour size, 
increasing surgical options and likelihood of breast conservation surgery (Connolly & Stearns, 




reducing recurrence risk, particularly distance recurrence (Condorelli & Vaz-Luis, 2018; 
Shapiro & Rech, 2001; Tao et al., 2015). 
There are multiple drugs and drug combinations for chemotherapy treatment, each with 
their own specific mechanism of action. Drug selection is guided by patient factors such as; 
age, concurrent medical issues, status of the hormone receptors and lymph node involvement 
(Kantarjian et al., 2011; Tobias & Hochhauser, 2015). The most common classes of breast 
cancer chemotherapy drugs include Anthracyclines (Epirubicin and Doxorubicin), Taxanes 
(paclitaxel and docetaxel), Antimetabolites (e.g. 5-fluorouracil and methotrexate), Alkylating 
agents (e.g. cyclophosphamide) and monoclonal antibodies/targeted therapy (Trastuzumab, 
Pertuzumab) (Tobias & Hochhauser, 2015). Chemotherapy drugs are most commonly used in 
combination and are rarely administered as a single agent. Combination approaches using 
multiple drugs is done to circumvent multiple-resistance mechanisms (Brighton & Wood, 
2005; Tobias & Hochhauser, 2015).  
 Chemotherapy drugs are highly toxic, and this toxicity is associated with many acute, 
chronic, and late side effects that have a significant impact on patients’ lives. The main 
functions of cytotoxic drugs are to either directly damage cancer cell DNA or to block synthesis 
of the DNA. While effects on cancer cell DNA are effective at destroying malignant cells, 
chemotherapy drugs are unable to distinguish between cancer cells and normal cells, resulting 
in detrimental effects on normal cell function (Tobias & Hochhauser, 2015).  
Acute side effects are seen during treatment and are generally reversible. Chemotherapy 
affects the rapidly dividing cells of the body, such as hair and nail cells, and the immune 
system, leading to hair and nail loss and immunosuppression (Brighton & Wood, 2005; 
Ehrman, Gordon, Visich, & Keteyian, 2013; Kantarjian et al., 2011; Neal & Hoskin, 2009; 
Tobias & Hochhauser, 2015). Most of these side effects are short term and generally disappear 




regrowing (Kantarjian et al., 2011; Tobias & Hochhauser, 2015). Vomiting, fatigue, and nausea 
are also common acute side effects due to the toxicity of chemotherapy drugs, while 
chemotherapy induced anaemia is one that is less common (Beard & Tobin, 2000; Dolan et al., 
2010; Kantarjian et al., 2011; Volkova & Russell, 2011). 
 Chronic effects of chemotherapy include neuropathy and decreased bone mineral 
density, while late effects include pulmonary fibrosis, congestive heart failure (CHF) and 
treatment related pneumonitis (Aleman et al., 2014; Guo, Zhang, Reynolds, & Foraker, 2020; 
Lotrionte et al., 2013; Pin, Couch, & Bonetto, 2018; Tao et al., 2015; Visovsky, 2006; Youssef 
& Links, 2005; Yu & Jones, 2016). Chronic effects of systemic treatment can be seen soon 
after treatment completion and are potentially permanent (Tao et al., 2015; Tobias & 
Hochhauser, 2015). Chemotherapy induced peripheral neuropathy (CIPN) is caused by 
neurotoxicity of chemotherapy agents such as taxanes (paclitaxel and docetaxel) and platinum 
drugs (carboplatin and cisplatin) (Bao et al., 2016; Eckhoff, Knoop, Jensen, & Ewertz, 2015; 
Tobias & Hochhauser, 2015). Chemotherapy induced peripheral neuropathy is damage to the 
nerves, particularly of the hands and feet. Development of CIPN can occur within weeks or 
months after the onset of chemotherapy treatment and can last for months or years after 
treatment completion (Cavaletti & Marmiroli, 2010; Eckhoff et al., 2015). Chemotherapy 
induced peripheral neuropathy can contribute to a reduction in balance and functional 
capabilities in breast cancer survivors, increasing falls risk (Bao et al., 2016; Gewandter et al., 
2013; Kneis et al., 2016; Marshall, Zipp, Battaglia, Moss, & Bryan, 2017). Although drugs act 
on cancer cells, non-dividing neurons and supporting cells in the peripheral nervous system 
can also be affected (Bao et al., 2016; Cavaletti & Marmiroli, 2010; Windebank & Grisold, 
2008). If CIPN appears during treatment, it can be a potential dose-limiting factor for 
chemotherapy (Cavaletti & Marmiroli, 2010). Osteoporosis is another chronic risk of breast 




cyclophosphamide and 5-fluorouracil, can lead to early menopause in women, leading to a 
decrease in estrogen production, negatively impacting bone density (Axelsen, Jensen, 
Jakobsen, & Bechmann, 2018; Kalder & Hadji, 2014; Pfeilschifter & Diel, 2000; Wissing, 
2015). 
 Late side effects potentially impacting cardiorespiratory and vascular systems can 
develop as late as 10-20 years after chemotherapy completion (Aleman et al., 2014; Hooning 
et al., 2007; Pinder, Duan, Goodwin, Hortobagyi, & Giordano, 2007; Youssef & Links, 2005). 
Late effects of chemotherapy are effects that may not be present during or immediately after 
treatment completion but develop and appear in later years (Aleman et al., 2014; Patnaik et al., 
2011; Youssef & Links, 2005). Treatment related pneumonitis is rare and seen most commonly 
in chemotherapy treatment involving docetaxel, paclitaxel, cyclophosphamide and 
gemcitabine (Kim, Tannock, Sridhar, Seki, & Bordeleau, 2012). Treatment related 
pneumonitis can occur from both chemotherapy and radiation therapy. In the chemotherapy 
setting, drugs can inflame the alveoli, restricting the ability to pass air through the lungs and 
into the blood (Kim et al., 2012). Pulmonary fibrosis is a disease where lung tissue becomes 
scarred and stiff and can result from chemotherapy treatments involving methotrexate and 
cyclophosphamide (Chap et al., 1997). Stiffening of the lung wall decreases lung compliance, 
reducing the lungs ability to expand and contract (Bentzen, Skoczylas, Overgaard, & 
Overgaard, 1996). The cardiotoxic effects of systemic treatment can lead to myocardial cell 
death, particularly after anthracycline-based chemotherapy, resulting in CHD or CHF, where 
the heart is unable to meet the body’s requirements (Aleman et al., 2014; Lotrionte et al., 2013; 
Volkova & Russell, 2011; Youssef & Links, 2005). One of the most common causes of heart 
failure in breast cancer survivors is a decreased left ventricular ejection fraction (LVEF), which 
can be seen after anthracycline chemotherapy, in particular doxorubicin or Trastuzumab 





 Radiation therapy utilises high dose radiation to kill or reduce the size of malignant 
cells. Ionizing radiation is targeted at the centre of the tumour area and disrupts the cell cycle, 
inducing apoptosis (Halperin et al., 2008). When treating breast malignancy, it is most 
commonly administered through external beam radiation into the breast (LaRiviere et al., 
2020). Treatment is usually administered daily five days a week, for a period of three to five 
weeks. As a localised treatment targeting a specific area of the body, radiation, like 
chemotherapy, can be undertaken in the neoadjuvant or adjuvant setting (Khan, 2007). 
Neoadjuvant radiation treatment aims at reducing the size of the tumour, increasing the chance 
of breast conservation surgery (lumpectomy) instead of a mastectomy (Cox & Ang, 2010; 
Joiner & Kogel, 2009; Khan, 2007). Adjuvant radiation aims to kill any malignant cells 
remaining after the tumour has been surgically removed (Joiner & Kogel, 2009; Khan, 2007; 
Valente & Shah, 2020).  
 Although radiation treatment targets the tumour, there can be collateral damage to 
healthy cells surrounding the radiated side. Acute side-effects of radiation treatment include 
fatigue, nausea, diarrhoea, erythema, breast oedema, desquamation and pericarditis (Halperin 
et al., 2008; Khan, 2007; Kuhnt, Reichter, Enke, & Dunst, 1998; Kurtz, 2002; LaRiviere et al., 
2020; Lopez et al., 2005). Appearing during or immediately after radiotherapy treatment, these 
side effects generally resolve rapidly after cessation of treatment (Kurtz, 2002; Lopez et al., 
2005). Acute pericarditis occurs through inflammation of the pericardium through radiation, 
causing chest pain and fevers (Armanious et al., 2018; Madan et al., 2015). Physiologically, 
acute side effects of radiation treatment can stem from changes in the cell environment, with 
inflammatory cytokines stimulated by radiation influencing normal cell function, signalling 
apoptosis and inflammatory processes, leading to detrimental effects on normal cell function 




 Chronically, radiation can lead to side effects such as radiation induced lung injury 
(RILI) and lymphedema (Garibaldi et al., 2017; Harbeck et al., 2011; Senkus-Konefka & 
Jassem, 2007; Yeh et al., 2004; Yu & Jones, 2016). Radiation treatment may also affect the 
heart, especially for cancer located in the left breast (Chen & Kuo, 2017; Darby et al., 2013; 
Gigliardi, Lax, & Rutqvist, 2001; Hanania, Mainwaring, Ghebre, Hanania, & Ludwig, 2019; 
Shapiro & Rech, 2001; Wei et al., 2019; Wennstig et al., 2020; Yeh et al., 2004; Yu & Jones, 
2016). 
Radiation induced lung injuries include radiation pneumonitis and pulmonary fibrosis, 
both of which lead to reduced lung compliance and function (Wei et al., 2019). Radiation 
pneumonitis is an inflammation of the lungs and chronic pneumonitis can lead to permanent 
scarring of the lungs, termed pulmonary fibrosis (Hanania et al., 2019; Kuhnt et al., 1998). 
Radiation pneumonitis generally develops one- to six-months after treatment, while pulmonary 
fibrosis can be present between six- to twenty-four months post treatment (Hanania et al., 
2019). Inflammation of the lungs is caused by reactive oxygen and nitrogen species that 
upregulate several enzymes that cause RILI (Wei et al., 2019). Damage to the lungs can lead 
to activation of intrinsic repair mechanisms, ultimately scarring lung tissue through fibroblast 
proliferation, decreasing compliance and function (Hanania et al., 2019; Wei et al., 2019). 
Lymphedema is another chronic side-effect of radiation treatment, with regional lymph 
node radiation increasing the risk of lymphedema among breast cancer survivors (Rupp et al., 
2019; Warren et al., 2014). Lymphedema results in swelling of the upper limb caused by a lack 
of fluid drainage by the lymphatic system, and most commonly appears within two years of 
treatment (Rupp et al., 2019; Warren et al., 2014).  
A late effect of breast cancer radiation therapy is radiation induced heart disease 
(RIHD) and includes coronary heart disease (CHD) and heart failure (Darby et al., 2013; 




Radiation induced fibrosis can occur through the stimulation of inflammatory mediators such 
as IL-4 and IL-13, and can lead to heart failure, through fibrosis in the myocardium, and 
arrythmias, through fibrosis in the conductive tissue of the heart (Madan et al., 2015). Due to 
the high survival rate of breast cancer and treatments associated negative side effects, CHD is 
the leading cause of death among breast cancer survivors (Guo et al., 2020). Coronary heart 
disease involves damage to the major blood vessels that supply the heart and can appear as late 
as ten or more years after radiation treatment (Guo et al., 2020; Harris et al., 2006; Park et al., 
2017; Patnaik et al., 2011). Ionizing radiation can affect coronary arteries and lead to fibrosis 
and collagen formation in arteries, restricting diastolic blood flow, which in turn can lead to 
ischemia (Darby et al., 2013; Gigliardi et al., 2001; Yusuf, Venkatesulu, Mahadevan, & 
Krishnan, 2017). In summary, radiation is minimally invasive and is effective as part of a 
multifaceted treatment regimen at improving survival rate from breast cancer as well as 
decreasing recurrence rate (Joiner & Kogel, 2009; Khan, 2007). 
Surgery 
 Surgery is the most frequently used treatment for breast cancer. It is undertaken to 
remove the tumour, permit staging and grading of the malignancy and provide reconstruction 
(Kantarjian et al., 2011; Poston, Beauchamp, & Ruers, 2007; Sabel et al., 2007). Two main 
types of surgical intervention exist for breast cancer patients: breast-conservation or total 
excision surgery. Small and early detected tumours allow for breast conserving surgery, an 
operation involving removing only the tumour (a lumpectomy or wide local excision), 
generally followed by chemotherapy and/or radiation (Kantarjian et al., 2011; Poston et al., 
2007; Sabel et al., 2007). If the individual presents with a large tumour, the presence of multiple 
tumours, or contraindications to breast conservation therapy, a mastectomy may be performed 
(removal of the entire breast) (Kantarjian et al., 2011; Poston et al., 2007; Sabel et al., 2007). 




breast, and small breast size (Poston et al., 2007). In patients where breast conservation therapy 
is not practical, neoadjuvant treatment of chemotherapy and/or radiation, may reduce tumour 
size, consequently making breast conservation therapy an option (Sabel et al., 2007). 
Surgery is not without side effects, both acute and chronic. Acute complications can 
include pain and bruising around the operated site, risk of infection and cardiorespiratory 
complications of anaesthetic. Acute pain after surgical treatment can result from injury to 
muscle and ligaments around the operated site and is generally transient (Agrawal, 2014; 
Hovind, Bredal, & Dihle, 2013). Upper limb movement and function may be affected after 
breast cancer surgery, whether breast conservation or wide local incision. Anaesthetics’ 
sedative components can impair respiratory function, decreasing oxygenation of blood. 
Chronic symptoms include a loss of nerve sensation to the area, weight imbalance, cosmetic 
issues, restrictions to range of movement of the shoulder area, and lymphedema (Kantarjian et 
al., 2011; Poston et al., 2007; Sabel et al., 2007; Swenson, 2002). Breast surgery can damage 
nerves in the chest, causing numbness in the chest, armpit or the upper arm, which can last 
from a few weeks to becoming a permanent condition. (Swenson, 2002). Weight imbalance is 
most common after a mastectomy and can cause discomfort or pain (Poston et al., 2007).  
Another potential complication following surgical intervention is lymphedema. The 
lymphatic system maintains fluid balance in the body and when disrupted can lead to a build-
up of fluid in tissues, also known as lymphedema (Hayes, Janda, Cornish, Battistutta, & 
Newman, 2008; Lin et al., 1993; Ozaslan & Kuru, 2004). Two main lymph node dissections 
can be performed, sentinel lymph node dissection or axillary lymph node dissection (ALND). 
Both are associated with chronic side effects of pain, nerve damage and lymphedema (Lin et 
al., 1993; Rupp et al., 2019; Steegers, Wolters, Evers, Strobbe, & Wilder-Smith, 2008). 
Sentinel lymph node dissection is the removal of the sentinel lymph node, the primary node 




nodes from the axilla area (Swenson, 2002). Sentinel lymph node dissection is associated with 
fewer side effects than ALND post-surgery (Swenson, 2002). Lymphedema can appear within 
days of surgery, or up to 30 years after treatment completion. Symptoms include swelling and 
heaviness in the affected limb, skin tightness and decreased flexibility of joints (Agrawal, 2014; 
Hayes et al., 2008; Ozaslan & Kuru, 2004; Rupp et al., 2019; Steegers et al., 2008). Axillary 
radiotherapy and BMI >25kg/m2 increase the risk for lymphedema (Ozaslan & Kuru, 2004). 
Compression garments help to generate pressure and increase fluid movement in the affected 
limb, providing relief for lymphedema (Cheville et al., 2003). 
In the event of a mastectomy, patients may undergo breast reconstruction, with the aim 
to return to normal cosmetic appearance, either concurrently to tumour removal, or at a later 
date (Kallaway, Humphreys, Laurence, & Sutton, 2016; Sabel et al., 2007). Some consider 
immediate reconstruction can help improve quality of life among breast cancer survivors (Kim 
et al., 2015). Breast reconstruction is undertaken using implants, or with a flap (using tissue 
from other parts of the body). Breast implant insertion is a relatively straightforward procedure. 
In addition to the general surgical side effects mentioned the main concerns are implant issues 
such as rupture and the limited lifespan of the procedure (10-20 years) (Handel, Cordray, 
Gutierrez, & Jensen, 2006). Flap reconstructions involve two options for donor sites, the 
patients’ upper back, specifically the latissimus dorsi muscle, or the abdomen, known as a 
transverse rectus abdominis myocutaneous (TRAM) flap. The latissimus dorsi muscle, is a 
large muscle that is used for reconstruction without significant loss of function (Kallaway et 
al., 2016). Most latissimus dorsi reconstructions also require an implant under the dorsi flap to 
achieve the desired breast size (Kallaway et al., 2016). A TRAM flap can provide a better 
cosmetic result but can result in abdominal wall weakness and decreased functionality (Dulin, 
Avila, Verheyden, & Grossman, 2004; Styblo et al., 1996). Risks of these surgeries include 




Surgical treatment, either lumpectomy or mastectomy, as well as reconstructive 
treatment can improve both survival rate and quality of life in breast cancer survivors 
(Anderson et al., 2012; Kallaway et al., 2016; Kim et al., 2015; Poston et al., 2007). 
Endocrine Treatment 
Targeted endocrine therapies work by blocking the growth and spread of tumours 
through the inhibition of the specific molecules required for tumour growth (Kantarjian et al., 
2011; Neal & Hoskin, 2009; Pecorino, 2012). Targeted therapies used to treat breast cancer 
include Trastuzumab, Pertuzumab, Tamoxifen and AIs. 
 Trastuzumab and Pertuzumab are humanized monoclonal antibodies used to treat HER-
2 positive breast cancer, and can be used individually, in combination with each other, or in 
combination with other treatments (Giordano et al., 2014; Kantarjian et al., 2011; Masoud & 
Pagès, 2017; Nahta & Esteva, 2006; Piccart-Gebhart et al., 2005). These two treatments are 
delivered intravenously. The HER-2 gene is overexpressed in 20-25% of invasive breast 
cancers and is associated with a reduced survival rate. This overexpression stimulates cell 
proliferation through an increase in growth-promoting signals, giving HER-2 positive cancers 
aggressive characteristics (Piccart-Gebhart et al., 2005). The role of Trastuzumab and 
Pertuzumab are to block these growth-promoting signals, each working on different parts of 
the HER-2 receptor. Both are effective at improving disease free survival in patients with HER-
2 positive breast cancer (Giordano et al., 2014; Masoud & Pagès, 2017; Nahta & Esteva, 2006; 
Piccart-Gebhart et al., 2005). Acute side effects are similar to those of chemotherapy, including 
nausea and fatigue (Kantarjian et al., 2011; Stebbing, Copson, & O'Reilly, 2000). These side 
effects, like those experienced in chemotherapy, generally disappear once treatment is over. 
They occur through negative effects of targeted therapies on normal cell function (Gemmete 
& Mukherji, 2011; Giordano et al., 2014; Teicher, 2006). Pertuzumab is the less common of 




The long-term impact of these treatments can lead to cardiac dysfunction, including 
decreased LVEF and CHF (Masoud & Pagès, 2017; Monsuez, Charniot, Vignat, & Artigou, 
2010; Yoon et al., 2010). Decreased LVEF can occur after Trastuzumab treatment, but this 
returns to normal post-treatment in the majority of patients who experience it (Advani, 
Ballman, Dockter, Colon-Otero, & Perez, 2016; Gemmete & Mukherji, 2011; Masoud & 
Pagès, 2017; Yoon et al., 2010; Youssef & Links, 2005). 
Hormonal therapies are used to block either the production or binding of estrogen. They 
are used in estrogen receptor-positive (ER-positive) breast cancers. Tamoxifen and AIs 
(Anastrozole, Letrozole and Exemestane) are the most commonly used hormonal therapy 
treatments for breast cancer patients (Garreau, Delamelena, Walts, Karamlou, & Johnson, 
2006). Tamoxifen blocks the estrogen receptor and is used in both pre- and post-menopausal 
women (Buckley & Goa, 1989; Kantarjian et al., 2011; Pecorino, 2012; Rafi, 2006; Teicher, 
2006). Administered orally, Tamoxifen is typically taken for five to ten years. Side effects are 
related to the anti-estrogenic activity of the drug and include nausea, vomiting, hot flushes, 
vaginal bleeding or discharge, and menstrual disturbances in pre-menopausal patients (Buckley 
& Goa, 1989; Garreau et al., 2006; Pinedo & Smorenburg, 2006). 
 Aromatase inhibitors are also used in the treatment of ER-positive breast cancers. 
Aromatase inhibitors block estrogen production by inhibiting the function of the enzyme 
aromatase, a key regulator in the synthesis of estrogen (Garreau et al., 2006; Krasenska, 2016). 
In estrogen receptor-positive breast cancers, estrogen binds to tumour receptors and 
upregulates cell growth and replication (Kantarjian et al., 2011; Neal & Hoskin, 2009; 
Pecorino, 2012). While the ovaries are the main source of estrogen, it can also be produced in 
other tissues such as adipose tissue (Pecorino, 2012). Aromatase inhibitors are mainly used in 
post-menopausal women where ovarian production of estrogen has ceased. Anastrozole, 




Exemestane is a steroid, while Anastrozole and Letrozole are non-steroidal drugs (Pecorino, 
2012). Acute side-effects are similar to those seen in menopause, such as hot flushes and 
vaginal dryness, as well as tiredness, mood swings and muscle and joint pain or stiffness 
(Garreau et al., 2006; Krasenska, 2016; Neal & Hoskin, 2009; Pecorino, 2012). Estrogen is a 
key hormone in bone growth and resorption, with chronic reduction in estrogen production 
leading to osteoporosis (Condorelli & Vaz-Luis, 2018; Krasenska, 2016; Mincey et al., 2006). 
Prevalence of bone loss and bone fracture is higher among breast cancer patients receiving AIs 
when compared with controls not receiving AI therapy (Mincey et al., 2006). 
 Every breast cancer differs to some degree, with factors such as age, type and stage of 
tumour, lymph node involvement, menopausal status, receptor status and other comorbidities 
all influencing the treatment regimen. Responses to treatment vary considerably in individuals. 
Acutely, hair-loss, fatigue and nausea are the most common among different treatments, while 
the most common long-term effects include adverse effects on the cardiovascular and 
cardiorespiratory systems. With improving treatment methods leading to increasing survival 
rates of breast cancer survivors, late effects of cancer treatment are a growing concern (Madan 
et al., 2015). 
Cardiorespiratory fitness 
The cardiac and respiratory systems are both affected by cancer treatments, with 
chemotherapy, radiation, surgery, and endocrine therapies all contributing to impairments of 
these physiological systems. The physiological impairments stem from the side-effects of 
treatments such as chemotherapy induced anaemia, pulmonary fibrosis, decreased LVEF, 
treatment-related pneumonitis and anaesthesia effects from surgery (Beard & Tobin, 2000; 
Chen, Wu, & Ning, 2019; Harbeck et al., 2011; Kantarjian et al., 2011; Poston et al., 2007; 
Schneider, Hsieh, Sprod, Carter, & Hayward, 2007). Cardiorespiratory fitness (CRF) is an 




working muscle (Lumb, 2010; McKenzie, 2012; Mines, 1993; West, 2012). There exists an 
inverse relationship between CRF and both the all-cause mortality risk and CVD (Lee et al., 
2010). An important indicator of health, increased CRF is shown to have a beneficial effect in 
decreasing risk of CVD, all-cause mortality and recurrence risk experienced by patients 
receiving cancer treatments (Adams et al., 2017; Gibala et al., 2012; Lee et al., 2010; 
McKenzie, 2012; Nystoriak & Bhatnagar, 2018; Stocci et al., 2007). 
Cardiorespiratory physiology 
 The function of the cardiorespiratory system is reflected in the integration of the 
respiratory system and the cardiac system. Both at rest and in exercise settings, the body must 
receive and delivery oxygen to working muscles, in addition to removing waste products such 
as carbon dioxide. Combined, the heart and lungs oxygenate blood, deliver it, then exchange 
oxygen and carbon dioxide at the tissue level. Cardiorespiratory function can be assessed 
through CRF tests, including maximal and sub-maximal prediction testing methods (ACSM, 
Swain, Brawner, & Medicine, 2014). Specific testing protocols exist for both elite and clinical 
populations and can be adapted to fit the population or testing environment (De Backer et al., 
2007; Dieli-Conwright, Courneya, et al., 2018; Dolan et al., 2018; Kampshoff et al., 2015; 
Paulo et al., 2018). 
 Gas transportation 
Three main factors determine the ability of the body to deliver oxygen to working 
muscle: the loading of oxygen into the blood, the delivery of oxygenated blood to working 
muscle, and the subsequent offloading of oxygen from blood to muscle (Lumb, 2010; Mines, 
1993; West, 2012). The greater capacity for oxygen delivery, the greater an individual’s 
exercise capacity (Murias, Kowalchuk, & Paterson, 2010; Nystoriak & Bhatnagar, 2018). 
Gas exchange occurs at two main sites: the alveolar-capillary barrier, where oxygen is 




into muscle and carbon dioxide is loaded into the blood for exhalation (Lumb, 2010; Mines, 
1993; West, 2012). Oxygen and carbon dioxide movement is dependent on concentration 
gradients and diffusion coefficients. 
Transport of oxygen in the bloodstream occurs primarily via haemoglobin, where 
oxygen binds to and is carried in the bloodstream around the body. Due to its oxygen carrying 
ability, haemoglobin is an important factor for health and exercise capacity, with a reduction 
in haemoglobin levels (i.e., anaemia) leading to a decrease in oxygen-carrying capacity (Beard 
& Tobin, 2000; Dolan et al., 2010; Mines, 1993). 
Oxygen diffuses into muscles through capillaries, therefore increased capillarisation 
leads to greater oxygen transportation capacity through increased sites for oxygen offloading 
into the muscle (Lumb, 2010; West, 2012). Once in the muscle, oxygen can either bind to 
myoglobin, an oxygen binding protein found in skeletal muscle, or it can enter the mitochondria 
to be used in oxidative metabolism (Lumb, 2010; West, 2012). As with increased muscle 
capillarisation, an increase in mitochondrial density improves oxidative metabolism capacity 
through increased sites for oxidative metabolism to occur (Murias et al., 2010). 
Effects of exercise on cardiorespiratory fitness 
 Oxygen consumption 
 Maximal oxygen consumption (V̇O2max) is the maximal volume of oxygen the body can 
consume and is an indicator of CRF (McArdle, Katch, & Katch, 2015). Three key components 
influence an individual’s exercise capacity; the ability to inhale oxygen and transport 
oxygenated blood to working muscle, the ability of working muscle to extract and use the 
delivered oxygen, and the ability of the body to clear metabolites such as carbon dioxide and 
hydrogen ions (H+) (Lumb, 2010; McArdle et al., 2015; Mines, 1993; Murias et al., 2010). 




(a-vO2diff) (V̇O2 = (heart rate x stroke volume) x a-vO2diff), with changes in these values 
affecting an individual’s fitness capacity (Mines, 1993; Murias et al., 2010).  
Cardiac output 
 Cardiac output is the product of stroke volume and heart rate and is an important aspect 
of fitness that increases with increased exercise intensity (McArdle et al., 2015). Stroke 
volume, the volume of blood ejected from the left ventricle per heartbeat, can be increased via 
increased myocardial contractility, or increased diastolic filling time (Schaible & Scheuer, 
1985). The ability to increase heart rate is another indicator of exercise capacity. While 
maximum heart rate (HRmax) decreases with age, regular exercise participation will decrease 
resting heart rate, allowing for a wider heart rate range and therefore greater exercise capacity 
(Hsieh et al., 2008; Schneider et al., 2007). 
Arteriovenous oxygen difference 
 Arteriovenous oxygen difference is the difference in oxygen saturation between arterial 
blood and venous blood and is an indicator of the ability of the body to uptake oxygen (Lumb, 
2010; Mines, 1993; Murias et al., 2010; West, 2012). Chronic exercise adaptations include 
increased skeletal muscle oxygen extraction efficiency from the blood, which in turn increases 
a-vO2diff (Jones et al., 2007; Lumb, 2010; Mines, 1993; West, 2012). Increased ability for 
oxygen extraction in muscles occurs via increased muscle capillarisation which increases the 
surface area for diffusion of oxygen into working muscle (Lumb, 2010; Murias et al., 2010; 
West, 2012). 
 Respiration 
 The two major functions of the pulmonary system are inhalation to provide oxygen and 
exhalation to remove carbon dioxide (Lumb, 2010; Mines, 1993; West, 2012). At rest, 
inhalation is caused by contraction of the diaphragm which expands the chest and increases 




lower than ambient air pressure, leading to airflow into the lungs (Lumb, 2010; Mines, 1993; 
West, 2012). 
Respiration increases during exercise, with breathing rate and depth increasing 
allowing for greater inspiration of oxygen and exhalation of carbon dioxide (Lumb, 2010; 
Mines, 1993). During exercise, the diaphragm is assisted by the scaleni, intercoastal muscles 
and abdominals, further increasing lung volume and air flow (McKenzie, 2012; West, 2012). 
In exercise, three states of oxygen consumption exist; oxygen deficit, steady-state, and oxygen 
debt (or, EPOC: excess post-exercise oxygen consumption) (Lumb, 2010; McKenzie, 2012). 
Oxygen deficit occurs in the initial few minutes of aerobic exercise commencing and reflects 
a momentary mismatch between the bodies supply and demand of oxygen. Steady-state 
exercise is where oxygen demands for energy production are met by inspiration and breathing 
becomes relatively constant. Oxygen debt occurs after the cessation of exercise. The body does 
not immediately cease requiring oxygen once activity stops, and oxygen consumption 
continues to occur post-exercise while the body is recovering (Lumb, 2010; McKenzie, 2012; 
West, 2012). 
 Chronic exercise leads to both structural and functional improvements in respiration. 
Functional improvements are increases in tidal volume and minute ventilation, which increase 
airflow into and out of the lungs, enhancing gas exchange (Lumb, 2010; Mines, 1993; West, 
2012). Additionally, increases in strength and endurance of respiratory muscles (intercostals, 
diaphragm, scaleni) allow for improved respiration for longer periods (Lumb, 2010; McKenzie, 
2012; Mines, 1993; West, 2012). Structural changes that aid in improved respiration include 
better lung pliability and increases in the number of alveoli in the lungs and capillaries in 
muscles. Improved lung pliability is seen by an increase in the lungs ability to expand, allowing 
a greater volume of air movement. Increases in alveoli and capillaries maximises the sites for 




Cardiorespiratory fitness (V̇O2peak) is a key indicator of health and has a strong inverse 
relationship with chronic disease risk and all-cause mortality (Barlow et al., 2012; Duscha et 
al., 2005). Exercise has a positive effect on CRF, with both aerobic and resistance activities 
able to increase CRF (Berger, Gerber, & Mayer, 2012; Milne, Wallman, Gordon, & Courneya, 
2008; Paulo et al., 2018). 
Cancer treatment effects on cardiorespiratory fitness 
 Cytotoxic effects of cancer treatment on the cardiorespiratory system can lead to a 
decrease in CRF among cancer survivors. A decrease in CRF impacts an individual’s ability to 
undertake activities of daily living (ADLs) (Jette et al., 1990; Wasserman et al., 2011). 
Activities of daily living are generally expressed as metabolic equivalents (METs). Metabolic 
equivalents are an objective measure used to express energy expenditure of daily activities and, 
like V̇O2, are expressed in mL/kg/min (Jette et al., 1990; Wasserman et al., 2011). One met is 
equal to 3.5 mL/kg/min of oxygen and is roughly equivalent to the energy expended sitting 
down (Wasserman et al., 2011). The negative impact these side effects have on exercise and 
physical activity, as well as individual’s confidence to be in an exercise setting, are well 
documented (Brighton & Wood, 2005; Ehrman et al., 2013; Kantarjian et al., 2011; Neal & 
Hoskin, 2009; Tobias & Hochhauser, 2015). 
 Chemotherapy 
 Side-effects of chemotherapy treatment directly affect an individual’s exercise 
capacity, with agents affecting heart and lung function (Dolan et al., 2010). Chemotherapy 
side-effects including chemotherapy-induced anaemia, decreased LVEF and pulmonary 
pneumonitis can lead to a reduction in CRF (Christensen et al., 2008; Fragkandrea et al., 2013; 
Kim et al., 2012; Van Belle & Cocquyt, 2003).  
Reduction in LVEF reduces the amount of blood ejected from the heart each beat 




blood circulating the body, limiting the supply of oxygen to working muscles (Mines, 1993; 
West, 2012). 
Chemotherapy induced anaemia reduces aerobic capacity through a reduction in the 
oxygen carrying capacity of the blood (Beard & Tobin, 2000; Dolan et al., 2010). Damage to 
bone marrow impairs red blood cell production. Reduction in red blood cell count reduces 
haemoglobin content, limiting oxygen carrying capacity of the body (Pirker et al., 2013). At 
rest, skeletal muscles receive 15-20% of total body blood flow, which increases to 80-85% 
during maximal exercise, and any impairment in the body’s oxygen carrying capabilities will 
affect exercise capacity (McArdle et al., 2015; Powers & Howley, 2011; Schneider et al., 
2007). 
 Pulmonary fibrosis decreases the compliance of the lungs, which can lead to a 
decreased respiratory capacity (Brighton & Wood, 2005; Harbeck et al., 2011; Lee, 2006). 
Lung tissue must be pliant to breathe, especially during exercise, and a reduction in pliability 
reduces the lungs ability to expand and inhale oxygen, consequently reducing delivery to 
muscle (Mines, 1993; West, 2012). Tests of pulmonary function in those with pulmonary 
fibrosis show reductions of forced vital capacity (FVC) and forced expiratory volume in one 
second (FEV1) and a reduction of gas transfer across the alveoli and into the bloodstream 
(Spyropoulou, Leotsinidis, Tsiamita, Spiropoulos, & Kardamakis, 2009). This reduction in gas 
transportation inhibits exercise capacity by reducing the ability of the heart and lungs to 
transport oxygen to working muscle (Abid, Malhotra, & Perry, 2001; Courneya et al., 2003; 
Lee, 2006; Mines, 1993; West, 2012). 
 While chemotherapy treatment can have detrimental effects on CRF, cancer survivors 
can attenuate reductions in their aerobic capacity through participation in regular exercise 




those after treatment, exercise is shown to have a positive effect on CRF, stroke volume and 
cardiac output (Casla et al., 2015; Dolan et al., 2010; Jones et al., 2007; Schulz et al., 2018). 
 Radiotherapy 
 Potential cardiac complications of radiation that can influence exercise capacity include 
lung dysfunction (radiation pneumonitis and fibrosis), valvular dysfunction (decreased LVEF) 
and pericardial disease (Hanania et al., 2019; Harbeck et al., 2011; Yu & Jones, 2016). Each 
of these complications can individually or collectively negatively impact cardiorespiratory 
capacity (Harbeck et al., 2011; Yu & Jones, 2016). Radiation effects on the cardiovascular and 
cardiorespiratory systems impair the body’s ability to inhale and transport oxygen to working 
muscle, limiting exercise capacity. Radiation induced heart and lung damage has decreased in 
recent years due to improved techniques and technology for radiation administration, with 
improvements in engineering and computing leading to greater precision, decreasing non-
malignant cell exposure (Chen & Kuo, 2017; Garibaldi et al., 2017). 
Surgery 
Breast cancer surgery can have both direct and indirect effects on CRF. There are rare 
but potentially significant complications that can be seen acutely after surgery, including blood 
loss and reduction in haemoglobin levels. Infection is another possible complication with 
surgery that can prolong recovery time and return to normal activity. The most significant side-
effect of surgical treatment is the associated pain and the impact that has on an individual’s 
ADLs (Hovind et al., 2013). General anaesthesia from surgical treatment is also known to 
impair the cardiorespiratory system, however, these effects are more likely to be short term if 
no underlying heart or lung disease is present (Poston et al., 2007; Sabel et al., 2007). In the 
long term, anaesthesia can reduce the body’s ability to regulate cardiac variables such as 




components of anaesthesia can also reduce respiratory function, with a decrease in oxygenation 
of blood. 
 Lymphedema is associated with surgery as well as radiation therapy and can impair 
exercise participation, indirectly affecting CRF (Smoot, Johnson, Duda, Krasnoff, & Dodd, 
2012). It can cause pain, inhibited range of motion and an associated recommended avoidance 
of exercise that can all affect fitness levels. 
Following surgical intervention, injury to muscle and ligaments around the operated 
site can cause pain and discomfort, as well as limit shoulder range of motion, which potentially 
inhibiting exercise participation (Agrawal, 2014; Hovind et al., 2013; Lin et al., 1993; Smoot 
et al., 2012; Steegers et al., 2008; Swenson, 2002). After breast surgery, it is recommended 
individuals avoid intense exercise for anywhere between four and twelve-weeks post-surgery, 
depending on the type of surgical intervention. Such a period of time without exercise can lead 
to a reduction in cardiorespiratory capacity, especially in patients who were physically active 
prior to surgery (Kantarjian et al., 2011; Kim, Kim, & Park, 2019). For previously active breast 
cancer survivors, returning to exercise can be difficult or frustrating, as exercise intensity needs 
to be reduced to account for the decreased exercise capacity (Anderson et al., 2012; Kim et al., 
2019). Studies have found that initiating exercise as soon as possible after surgery can have 
positive effects on exercise capacity in people who have undergone breast cancer surgery 
(Anderson et al., 2012; Kim et al., 2019). 
Body composition 
 Unfavourable body composition is associated with an increased risk of breast cancer, 
breast cancer recurrence and CVD such as heart failure, diabetes and coronary artery disease 




Irwin et al., 2005; Prineas, Folsom, & Kaye, 1993; Schapira et al., 1994; White, Nichols, 
Bradshaw, & Sandler, 2015). 
 Increased fat mass, specifically around the abdomen, is a significant risk factor for both 
risk of initial breast cancer, as well as recurrence among survivors. Sedjo et al. (2014) observed 
an average weight gain during treatment of 4.5% body weight among overweight and obese 
breast cancer survivors, with 44% of women experiencing weight gain of greater than 5% of 
initial body weight. A meta-analysis of weight gain during chemotherapy found an average 
weight gain of 2.7kg (Van den Berg et al., 2017). Physical activity can provide favourable 
changes to body composition (Battaglini et al., 2007; Casla et al., 2015; Dalleck et al., 2009; 
Heinrich et al., 2015; Irwin et al., 2009; Paulo et al., 2018; Sperlich et al., 2017). For all exercise 
modalities, a dose-response relationship exists between exercise and waist circumference 
(Dalleck et al., 2009). Aerobic, resistance and combined exercise interventions are shown to 
decrease central adiposity, BMI, waist circumference total body weight and total fat mass, 
while resistance training especially has been shown to increase lean tissue mass (Battaglini et 
al., 2007; Casla et al., 2015; Heinrich et al., 2015; Irwin et al., 2009; Paulo et al., 2018; Sperlich 
et al., 2017). Research shows the benefits of lean tissue mass in both cancer treatment and 
survivorship and highlights the importance of exercise regimes aimed at increasing or retaining 
muscle mass (Battaglini et al., 2007; Demark-Wahnefried et al., 2001; Freedman et al., 2004; 
Mazzuca et al., 2018; Visovsky, 2006). 
 Reductions in CRF are common among breast cancer survivors after treatment, with 
negative impacts on the heart and lungs impairing an individual’s ability to undertake both 
exercise and ADLs (Jette et al., 1990; Wasserman et al., 2011). Acute, chronic and late-effects 
of cancer treatment such as chemotherapy-induced anaemia, pulmonary fibrosis, decreased 




physiological function (Beard & Tobin, 2000; Chen et al., 2019; Harbeck et al., 2011; 
Kantarjian et al., 2011; Poston et al., 2007; Schneider et al., 2007). 
Exercise training 
 Exercise has the ability to reduce the impact of negative side-effects associated with 
breast cancer treatment, as well as improve physical fitness and quality of life (Aleman et al., 
2014; Hooning et al., 2007; Pinder et al., 2007; Swenson, 2002; Youssef & Links, 2005). 
Cancer treatment related impairments can inhibit an individual’s ability to undertake both 
exercise and ADLs (Jette et al., 1990; Wasserman et al., 2011). Exercise can attenuate this 
reduction in physiological capacity, with chronic exercise leading to both beneficial 
adaptations and reductions in the harmful side-effects of cancer treatment (Bird & Hawley, 
2016; Brenner & Eisenberg, 1987; Cipryan, Tschakert, & Hofmann, 2017; Cress, Conley, 
Balding, Hansen-Smith, & Konczak, 1996; Kneis et al., 2016; Owens, Twist, Cobley, 
Howatson, & Close, 2019; Sardeli et al., 2017; Stocci et al., 2007; Visovsky, 2006). Methods 
of exercise can vary, with different exercise modalities providing different benefits. 
Metabolic equivalents 
 Exercise intensity can be referred to in METs, with light intensity exercise 
approximately three METs, moderate intensity between three and six, and vigorous intensity 
exercise anything greater than six METs (Ainsworth et al., 2011). With V̇O2 and METs 
expressed in the same way (mL/kg/min), the MET system can be used to interpret V̇O2max/peak 
tests and assess an individual’s functional capacity. Increases in V̇O2max of 3.5 mL/kg/min 
improve an individual’s exercise capacity by 1 MET, which provides clinical importance (Jette 
et al., 1990; Peel et al., 2009; Wasserman et al., 2011). An increase in 1 MET can reduce 
mortality in breast cancer survivors (Peel et al., 2009). Cardiorespiratory fitness improvements 




men (Kokkinos et al., 2010; Myers et al., 2002). Therefore, exercise interventions that increase 
V̇O2 by at least 3.5 mL/kg/min are of clinical importance. 
Exercise prescription 
 Exercise can be undertaken in a multitude of different ways, from aerobic to resistance, 
high-intensity to moderate-intensity, or a combination. For aerobic exercise, intensity is often 
expressed as a percentage of either V̇O2max, V̇O2peak, HRmax or heart rate reserve (HRR). 
Resistance training is usually prescribed as a percentage of 1-repetition maximum (1-RM). 
Physical activity, either aerobic or resistance, has a wide range of effects on the body. From 
acute effects such as increases in heart rate and respiration, a decrease in arterial peripheral 
resistance and a redistribution in blood flow, to chronic effects including increased insulin 
sensitivity, mitochondrial biogenesis, capillarisation, muscle hypertrophy and neurological 
adaptations (Bird & Hawley, 2016; Brenner & Eisenberg, 1987; Cipryan et al., 2017; Cress et 
al., 1996; Kneis et al., 2016; Owens et al., 2019; Sardeli et al., 2017; Stocci et al., 2007; 
Visovsky, 2006). 
Aerobic exercise 
 Aerobic exercise is exercise that can be sustained by the bodies aerobic metabolism and 
is effective at offsetting many of the acute, chronic and late side effects of cancer treatment 
(Berger et al., 2012; Duscha et al., 2005; Hsieh et al., 2008; Milne et al., 2008; Paulo et al., 
2018; Raptopoulos & Constantinou, 2020; Schneider et al., 2007; Wasserman et al., 2011; 
West, 2012). Walking, jogging, running, cycling, and swimming are all examples of aerobic 
exercise. Increases in aerobic exercise capacity (termed ‘aerobic fitness’) are associated with 
increases in CRF, which in turn decreases the risk of cancer recurrence and all-cause mortality 
(Gibala et al., 2012; Irwin et al., 2008; Lee et al., 2010; Peel et al., 2009; Stocci et al., 2007).  
V̇O2 is a relative measure of both exercise intensity and capabilities, with V̇O2max/peak 




as a percentage of V̇O2max/peak (ACSM et al., 2014; Lumb, 2010). V̇O2 is expressed in either 
absolute terms (litres per minute of oxygen, L/min) or relative to body weight (millilitres per 
kg of body weight per minute (mL/kg/min)). Heart rate is also used to express exercise intensity 
and is used more commonly as HRmax can be easily predicted. Maximum heart rate can be 
assessed through either an exercise stress test or predicted through general formulae. The most 
common HRmax prediction formulae are (220 – age) and (208 – (0.7 x age)) (Roy & Mccrory, 
2015; Tanaka, Monahan, & Seals, 2001). While (208 – (0.7 x age)) is generally more accurate, 
(220 – age) is seen to be easier to use (Roy & Mccrory, 2015; Tanaka et al., 2001). Although 
V̇O2 is an effective way to prescribe exercise, it is less commonly used than heart rate as it 
requires equipment to assess 
Moderate-intensity continuous training and high-intensity interval training are the two 
main modalities of aerobic training. Moderate-intensity continuous training is typically 
undertaken at 50-75% of exercise capacity (V̇O2max, V̇O2peak, HRmax or HRR) and does not 
involve rest periods. High-intensity interval training consists of alternating bouts of intense 
exercise and recovery periods. Recover periods in HIIT training are either active (continuing 
to exercise at a lower intensity) or passive (cessation of exercise) (ACSM et al., 2014; Anderson 
et al., 2012; Toohey et al., 2016). Both moderate-intensity continuous and high-intensity 
interval exercise are safe and effective for breast cancer survivors to undertake (Anderson et 
al., 2012; Battaglini et al., 2007; De Luca et al., 2016; Dieli-Conwright, Courneya, et al., 2018; 
Dolan et al., 2016; Herrero et al., 2006; Kampshoff et al., 2015; Leach et al., 2019; Lee, Kang, 
et al., 2018; Martin et al., 2015; Mijwel et al., 2018; Paulo et al., 2018; Schulz et al., 2018; 
Thomas et al., 2017; Turner, Hayes, & Reul-Hirche, 2004). 
 Aerobic exercise physiology 
 Muscle contraction is fuelled by adenosine triphosphate (ATP); however, there is only 




ATP-PCr energy system (Kenney, Wilmore, & Costill, 2012; Powers & Howley, 2011). For 
exercise to continue past an initial 10-15 second burst, muscles require energy from other 
sources. The body continuously needs to produce ATP to keep up with the demands of working 
muscle, with these systems being either the anaerobic glycolytic system or the aerobic system 
(Kenney et al., 2012). The anaerobic glycolytic system takes over after the depletion of the 
ATP-CP system and uses glucose from the blood or glycogen to rapidly form ATP without 
oxygen and lasts up until ~two minutes (Kenney et al., 2012; McArdle et al., 2015; Powers & 
Howley, 2011).  
The aerobic system takes over after the initial ~two minutes of exercise. The aerobic 
system can be broken down into three processes: aerobic glycolysis, the Krebs cycle and the 
electron transport chain. The three processes of the aerobic system all require a large amount 
of oxygen, hence the increase in respiration that occurs as exercise intensity increases (Mines, 
1993). Continuous aerobic exercise describes a condition when the fuel demands of exercising 
muscles is sustained by the body’s ability to produce ATP (Kenney et al., 2012; Lumb, 2010). 
 Acute and chronic effects of moderate-intensity training 
 Moderate intensity exercise usually consists of physical activity undertaken at 50-70% 
HRmax, generally ranging from 3-6 METs (ACSM et al., 2014). During moderate-intensity 
exercise, the main aim of the body is to transport oxygen to working muscle for oxidative 
respiration. Acutely, during a bout of moderate-intensity exercise, increases are seen in heart 
rate, stroke volume and respiration. These increases aid in the loading, transportation, and 
offloading of oxygen to working muscles. Other acute effects include vasodilation of 
capillaries, allowing for greater blood flow, increased blood pressure, and a redistribution of 
blood flow in the body toward working muscle and away from areas unneeded in exercise such 




 Chronic training of any modality can lead to adaptations to aid in increasing fitness 
levels. Moderate-intensity exercise is effective at increasing V̇O2max, insulin sensitivity, 
mitochondrial biogenesis, and angiogenesis (Bird & Hawley, 2016; Cipryan et al., 2017; Stocci 
et al., 2007). Chronic increases in V̇O2max stem from increases in a-vO2diff and increased cardiac 
output, increasing the ability for oxygen transport and extraction around the body 
Angiogenesis, increased skeletal muscle capillary density, and mitochondrial biogenesis, 
reduce the diffusion distance between capillaries and the mitochondria, increasing the ability 
for oxygen extraction (Granata, Oliveira, Little, Renner, & Bishop, 2017; Hoier, Passos, 
Bangsbo, & Hellsten, 2013; Stocci et al., 2007). Increased capillaries in muscle fibres occur 
through exercise-induced secretion of vascular endothelial growth factor, the most critical 
growth factor for capillarisation (Hoier et al., 2013). Increased mitochondrial density is 
regulated by peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a), 
the key protein in mitochondrial biogenesis. Moderate intensity exercise stimulates the release 
of this protein and over time leads to an increase in mitochondrial content within skeletal 
muscle (Kenney et al., 2012; Powers & Howley, 2011). 
 Acute and chronic effects of high-intensity training 
 High-intensity training consists of bouts of intense exercise alternated with either active 
or passive recovery periods (ACSM et al., 2014; Anderson et al., 2012; Toohey et al., 2016). 
When compared to moderate-intensity training, for a similar volume of exercise, a bout of HIIT 
induces higher blood lactate concentration, heart rate, blood pressure, relative V̇O2 and rating 
of perceived exertion (RPE) (Cabral-Santos et al., 2017). High-intensity interval training uses 
multiple energy systems depending on the length of the exercising intervals. The ATP-CP and 
glycolytic system are needed to reach high-intensity, and oxidative metabolic pathways are 
required to maintain this intensity for as long as possible (Cipryan et al., 2017). Anaerobic 




blood lactate peaks. Increased lactate, as well as increases in H+ and CO2, all occur within 
high-intensity bouts of exercise and trigger several processes in the body. Increased CO2 
stimulates chemoreceptors in the brain and lungs to increase breathing rate and depth, while 
increased CO2 and H+ concentrations in the muscles lead to greater offloading of oxygen from 
the blood, increasing the a-vO2diff (Lumb, 2010; Mines, 1993; West, 2012). Systolic blood 
pressure increases linearly with exercise intensity, corresponding with a greater stroke volume 
(Kenney et al., 2012; Powers & Howley, 2011). 
 Chronic adaptations of high-intensity interval training are similar to those seen in 
moderate-intensity training, with increases in skeletal muscle mitochondrial density, cardiac 
output, insulin sensitivity and V̇O2max (MacInnis & Gibala, 2017). Repeated HIIT training can 
aid in improving the body’s ability to clear lactic acid. Lactic acid is an indicator that the body 
has diminished oxygen for aerobic metabolism, with pyruvate, usually broken down through 
the citric acid cycle, being converted into lactic acid when oxygen is low (Kenney et al., 2012; 
Mines, 1993; Powers & Howley, 2011). Increasing lactic acid clearance helps to extend high-
intensity exercise duration. Exercise-induced increases in insulin sensitivity have a dose-
response relationship between exercise volume and intensity. High-intensity training 
stimulates the AMPK pathway, which plays a significant role in upregulating PGC-1a. When 
matched for work and compared to moderate-intensity training, HIIT is a time-efficient and 
potentially superior option to promote increases in PGC-1α (MacInnis & Gibala, 2017). While 
HIIT has some effect on angiogenesis, it is not as pronounced as that seen with chronic 
moderate-intensity training (Hoier et al., 2013). Increases in skeletal muscle oxidative capacity 
can reduce anaerobic energy system use at submaximal intensities (McArdle et al., 2015; 





 Resistance training involves working muscles against a weight or force and can involve 
the use of resistance bands, free weights, machines, or bodyweight. Resistance exercise 
programs provide significant (p<0.05) increases in muscular strength and endurance and are 
effective in both already active and previously inactive cancer survivors (Battaglini et al., 2007; 
De Luca et al., 2016; Dieli-Conwright, Courneya, et al., 2018; Herrero et al., 2006; Leach et 
al., 2019; Lee, Kim, & Jeon, 2018; Paulo et al., 2018; Schulz et al., 2018; Sprod, Hsieh, 
Hayward, & Schneider, 2010). ACSM guidelines for resistance training interventions aimed at 
increasing muscular strength are 2-3 sets of 8-12 repetitions at 60-70% one-repetition 
maximum (1RM) (ACSM et al., 2014). In comparison those for increasing muscle endurance 
are 2-4 sets of 15-25 repetitions at less than 50% 1RM (ACSM et al., 2014). Acute effects of 
resistance training include depletion of metabolites, hormone secretion, increased cardiac 
output and decreased arterial resistance. Chronic adaptations include neurological adaptations, 
hypertrophy, hormone sensitivity, increased bone density and favourable effects on body 
composition (Cress et al., 1996; Dal Maso, Longcamp, & Amarantini, 2012; Dieli-Conwright, 
Courneya, et al., 2018; Huovinen et al., 2016; Irwin et al., 2009; Patton & Thibodeau, 2013). 
 Resistance exercise physiology 
 All muscle contraction uses ATP whether aerobic or resistance exercise, with 
contraction using either aerobic or anaerobic respiration. The small stores of ATP in the 
muscles provide enough fuel for a few seconds of maximal contraction. However, beyond the 
initial 20-25 seconds of contraction aerobic metabolism is needed, with glucose and oxygen 
utilizing processes in the muscle to generate ATP (Brenner & Eisenberg, 1987; McArdle et al., 
2015; Powers & Howley, 2011). Within the muscle, contraction involves three main processes: 





 Acute and chronic effects of resistance exercise training 
 As with all exercise, resistance training acutely increases cardiac output, stimulating 
increases in heart rate, stroke volume and blood pressure and decreases in peripheral resistance 
(Dieli-Conwright, Courneya, et al., 2018; Patton & Thibodeau, 2013; Sardeli et al., 2017). 
Resistance training risks a large acute increase in blood pressure due to compression of blood 
vessels around the muscles (de Souza Nery et al., 2010). Another risk for increased blood 
pressure is the Valsalva manoeuvre, a holding of the breath, increasing intrathoracic pressure 
(Hackett & Chow, 2013; Zebrowska, Gasior, & Jastrzebski, 2013). Continuous breathing is 
important for safety during resistance movements. Acutely during resistance training, creatine 
phosphate and muscle-stored ATP are depleted, causing a reduction in power production if 
exercise is continued past this point, while intramuscular hydrogen levels increase (Brenner & 
Eisenberg, 1987; McArdle et al., 2015; Patton & Thibodeau, 2013). Immediately after 
resistance training, hormones are released to aid in the recovery and growth of muscle tissue. 
Microtears occur in muscles after physical exertion, mainly pronounced in resistance training, 
and are crucial to muscle growth. These microscopic tears may cause delayed onset muscle 
soreness, muscle pain that appears anywhere between 12-72 hours post-exercise, with the 
repair of these fibres aiding in muscle hypertrophy over time (MacIntyre, Reid, & McKenzie, 
1995; Owens et al., 2019).  
 Muscle hypertrophy is an increase in the size of muscle fibres in the body and is a 
favourable change in body composition among breast cancer survivors (Irwin et al., 2009; 
Mazzuca et al., 2018; Tonorezos & Jones, 2013). Increases in strength can also occur 
independently from increased muscle mass through neurological adaptations. Particularly 
prevalent initially in a resistance exercise program, two main neurological adaptations appear; 
increases in the number of motor units in the muscle stimulated for contraction and decreased 




in greater muscle fibre activation, increasing the strength of contraction (Patton & Thibodeau, 
2013). Stimulation of antagonist muscles decreases with strength training, allowing for 
increased efficiency of muscle contraction (Dal Maso et al., 2012). Hormone sensitivity 
increases seen in chronic exercise training include increased resting levels of steroid hormones, 
as well as increased sensitivity of skeletal muscle to circulating protein and steroid hormones. 
Resistance training can increase bone mineral density, which is particularly significant for 
breast cancer survivors, with the effect of chemotherapy and AI treatments on bone mass 
(Axelsen et al., 2018; Huovinen et al., 2016; Kalder & Hadji, 2014; Lite & Mejia, 2010; Mincey 
et al., 2006; Wissing, 2015). 
Exercise in breast cancer survivors 
 Exercise, whether aerobic, resistance, functional or a combination of these modalities, 
provides increases across many domains of fitness, from V̇O2peak, muscle strength, physical 
function and ability to ADLs (Anderson et al., 2012; Armanious et al., 2018; De Vreede et al., 
2005; Lite & Mejia, 2010; Mijwel et al., 2018; Raptopoulos & Constantinou, 2020; Yu & 
Jones, 2016). Exercise training can also have positive effects specific to breast cancer 
survivors, reducing side-effects of treatment and recurrence risk (Dolan et al., 2010; Kim et al., 
2019; Loprinzi & Cardinal, 2012; Raptopoulos & Constantinou, 2020; Schneider et al., 2007). 
ACSM guidelines for exercise among breast cancer survivors are similar to those of the general 
population; 30-minutes of moderate intensity three times per week, plus twice weekly 
resistance training. When matched with healthy individuals, breast cancer survivors have a 
lower CRF (Jones et al., 2012). 
Aerobic training 
 Aerobic training has positive effects for breast cancer survivors, with reductions found 
in treatment related side-effects, all-cause mortality, breast cancer recurrence and improved 




et al., 2003; Daley, Mutrie, Crank, Coleman, & Saxtron, 2004; Dieli-Conwright, Courneya, et 
al., 2018; Dolan et al., 2016; Herrero et al., 2006; Kampshoff et al., 2015; Martin et al., 2015; 
Murtezani et al., 2014; Sprod et al., 2010). The two main modalities of aerobic exercise are 
moderate-intensity continuous training and high-intensity interval training. 
 Continuous training 
 Continuous training is particularly suited for those initiating an exercise program early 
in their recovery. It is an exercise modality that is relatively easy to achieve. Examples of 
aerobic exercise include cycling, running, jogging and rowing. Commonly, stationary cycles 
and treadmills are used in exercise training interventions, as they can be undertaken in most 
populations, with the non-weight-bearing aspect of stationary cycling being particularly 
helpful. 
 The effects of continuous training on breast cancer survivors has induced clinically 
significant improvements in CRF (V̇O2max, V̇O2peak) (Brdareski et al., 2012; Courneya et al., 
2003; Dolan et al., 2016; Dolan et al., 2018). Increases in V̇O2max are found with exercise 
durations ranging from 20-60 minutes, with intensities ranging from 45-70% V̇O2max in both 
short and long (3- to 24-week) term interventions (Brdareski et al., 2012; Casla et al., 2015; De 
Luca et al., 2016; Dieli-Conwright, Courneya, et al., 2018; Giallauria et al., 2016; Hornsby et 
al., 2014; Paulo et al., 2018). V̇O2peak increases are seen in sessions ranging 15-60 minutes in 
length, with durations ranging from 3-22 weeks and intensities of 60-75% V̇O2peak (Courneya 
et al., 2003; Dolan et al., 2016; Dolan et al., 2018; Herrero et al., 2006; Schmitt, Lindner, 
Reuss-Borst, Holmberg, & Sperlich, 2016). Continuous exercise for breast cancer patients can 
provide statistically significant increases in V̇O2peak from pre- to post-intervention scores 
(p<0.05) (Courneya et al., 2003; Herrero et al., 2006; Schmitt et al., 2016) and (p<0.001) 




duration and cardiovascular health/CRF, with the more exercise one undertakes the greater 
health and fitness benefits gained (Dalleck et al., 2009; Kampshoff et al., 2015). 
 Continuous exercise provides significant increases in predicted CRF, intensities 
ranging from 40-75% HRR and duration from 15-40 minutes have found to provide statistically 
significant increases in predicted V̇O2max (p values ranging from <0.05 to <0.01) (Daley et al., 
2004; Martin et al., 2015; Murtezani et al., 2014; Rogers et al., 2013; Sprod et al., 2010; Toohey 
et al., 2016). 
 High-intensity interval training (HIIT) 
 High-intensity interval training consists of short periods of intense exercise interspersed 
with recovery periods. High-intensity intervals can range from 15-seconds to 4-minutes, with 
the length of the interval inversely related to how high the intensity is (Adams et al., 2017; 
Toohey et al., 2016). Shorter intervals of 15-30 seconds will be at maximal intensity, while 
longer intervals of three to four minutes, while still high-intensity, do not achieve maximal 
effort for the entire interval (Adams et al., 2017; Toohey et al., 2016). The work-to-rest 
relationship is most commonly 1:1 or 1:2, working for either the same or half the allocated rest 
period, with rest periods either active or passive. Similar to exercise duration, a dose-response 
relationship exists with exercise intensity, with high-intensity interval training allowing for 
superior physiological and cardiorespiratory benefit when compared to moderate intensity 
training for similar exercise volumes, (Cabral-Santos et al., 2017; Kampshoff et al., 2015). This 
superiority of HIIT training has been seen in both healthy and breast cancer populations 
(Cabral-Santos et al., 2017; Kampshoff et al., 2015). Due to this intensity-response 
relationship, high-intensity interval training can be a time-effecting option, providing the same 
benefits in a shorter time period, or increased benefits in the same time period (Dolan et al., 





 Over the same intervention period, HIIT protocols have found similar increases in 
breast cancer survivors’ cardiovascular fitness when compared to moderate-intensity training 
in shorter session times (Dolan et al., 2016; Kampshoff et al., 2015; Schmitt et al., 2016). 
Exercise interventions ranged from 3-12 weeks, with intervals ranging 30 seconds to 2-
minutes, intensities 55-95% V̇O2peak and work-rest ratios of 1:1 to 1:2 (Dolan et al., 2016; 
Kampshoff et al., 2015; Schmitt et al., 2016). Generally, in HIIT studies among breast cancer 
survivors, intervals begin lower, both in intensity and duration, and gradually increase 
throughout the intervention period. Cardiorespiratory fitness increases (V̇O2peak or V̇O2 at a 
given submaximal intensity) were similar between the high-intensity and moderate-intensity 
groups, however the exercise periods for the HIIT exercises were shorter when compared to 
the moderate-intensity exercise. 
 When matched for time, HIIT interventions provide more extensive benefits to CRF 
than moderate-intensity exercise (Kampshoff et al., 2015; Martin et al., 2015). Both moderate-
intensity and high-intensity exercise provide increased benefits in breast cancer populations 
compared to non-exercising control groups (Courneya et al., 2003; Daley et al., 2007; Dieli-
Conwright, Courneya, et al., 2018; Martin et al., 2015; Murtezani et al., 2014). High-intensity 
interval training is a feasible modality that is safe and effective at increasing CRF in breast 
cancer survivors (De Backer et al., 2007; Dolan et al., 2016; Kampshoff et al., 2015; Schmitt 
et al., 2016). 
Resistance training 
 Resistance training alone is less common than aerobic training or combined training, 
however, this method of training can provide benefits to breast cancer survivors even in the 
absence of other training modalities. Benefits to the musculoskeletal system, joints, quality of 
life and lymphedema can all be seen with resistance training (Benton & Schlairet, 2017; Brown 




al., 2009; Winters-Stone et al., 2012). Due to the varying types of resistance exercise 
prescription, there is yet to be a firm consensus on the ideal frequency, intensity and mode of 
resistance training among breast cancer survivors. However, multiple studies have found 
benefits with resistance exercise, despite varying loads of training. Training volume varies 
depending on the desired outcome from training. Resistance training can be directed towards 
increasing muscular strength or muscular endurance, with recommended sets and repetitions 
different for each method. 
 Training programs ranging from 8-weeks to one-year have found significant benefits 
in breast cancer survivors. Frequency among studies range from once-weekly up to thrice-
weekly training sessions. Programs implemented in studies generally focus on a full-body 
program targeting the major muscle groups (arms, chest, back, legs and core) (Benton & 
Schlairet, 2017; Brown & Schmitz, 2015; Hagstrom et al., 2016; Santos et al., 2019; Schmitz 
et al., 2009; Winters-Stone et al., 2012). A whole-body resistance program aims to attenuate 
the loss of lean body mass that can be experienced during cancer treatment (Battaglini et al., 
2007; Demark-Wahnefried et al., 2001; Freedman et al., 2004; Mazzuca et al., 2018; Visovsky, 
2006). 
Resistance training programs have reported increases in muscle strength ranging from 
19% to 29% in upper body and 20% to 39% in lower body (Benton & Schlairet, 2017; Brown 
& Schmitz, 2015; Hagstrom et al., 2016; Santos et al., 2019; Schmitz et al., 2009; Winters-
Stone et al., 2012). These strength gains increase capacity for ADLs and reduce the risk of 
adverse events such as falls.  
Due to the nature of treatment for breast cancer and the side-effects that accompany it, 
individualisation of exercise programs, particularly those involving resistance exercises, is key 
(Battaglini et al., 2007; Sprod et al., 2010). Acute post-treatment side-effects such as cording 




effects of surgical treatments such as a limited range of motion require further adaptations. 
(Kantarjian et al., 2011; Poston et al., 2007; Sabel et al., 2007; Swenson, 2002). Surgical 
reconstructions can impact the need for individualisation of exercise programs, with TRAM 
flap and latissimus dorsi reconstructions leading to significant alterations to exercise 
capabilities (Dulin et al., 2004; Kallaway et al., 2016; Styblo et al., 1996). For example, those 
who have had a TRAM flap reconstruction are advised to avoid core exercises in the sagittal 
plane (i.e., sit-ups). 
Combined training 
 Combined exercise training consists of both aerobic and resistance exercise undertaken 
within the same session. For example, performing 25-30 minutes of resistance exercises 
followed by 25-30 minutes of aerobic training (‘cardio’). This method of training is safe and 
effective in breast cancer populations and should be incorporated into exercise programs for 
breast cancer survivors (Battaglini et al., 2007; De Luca et al., 2016; Dieli-Conwright, 
Courneya, et al., 2018; Kampshoff et al., 2015; Leach et al., 2019; Lee et al., 2019; Thomas et 
al., 2017). The inclusion of resistance training into exercise programs increases lean body mass, 
muscular strength and/or endurance, quality of life, and helps to decrease the loss of physical 
function experienced during and after treatment (Battaglini et al., 2007; De Backer et al., 2007; 
Herrero et al., 2006; Mijwel et al., 2018; Okumatsu et al., 2019; Schulz et al., 2018; Sprod et 
al., 2010). Resistance training applied in combination with both high-intensity (Battaglini et 
al., 2007; De Backer et al., 2007; Kampshoff et al., 2015; Ortega & de Paz Fernández, 2016; 
Schulz et al., 2018), and moderate-intensity (Casla et al., 2015; De Luca et al., 2016; Dieli-
Conwright, Courneya, et al., 2018; Herrero et al., 2006; Kampshoff et al., 2015; Leach et al., 
2019; Lee et al., 2019; Thomas et al., 2017) training can also support improving 




 Combined exercise training is effective at increasing muscular strength and endurance. 
Resistance program components of combined interventions are similar to those of programs 
solely involving resistance training, with movements targeting all the major muscle groups 
(Battaglini et al., 2007; Dolan et al., 2018; Herrero et al., 2006; Leach et al., 2019; Milne et al., 
2008; Okumatsu et al., 2019; Paulo et al., 2018; Schulz et al., 2018; Sprod et al., 2010). 
Attenuation of cancer-related reductions in lean body mass through resistance training, when 
paired with the positive effects on body composition from aerobic exercise, means combined 
exercise training has effective body composition benefits for breast cancer patients and 
survivors (Battaglini et al., 2007; Casla et al., 2015; Dalleck et al., 2009; Heinrich et al., 2015; 
Irwin et al., 2009; Paulo et al., 2018; Sperlich et al., 2017). Resistance exercise prescription in 
a combined program generally follows ACSM prescription guidelines for resistance training 
aimed at increasing muscular strength (Dieli-Conwright, Courneya, et al., 2018; Kampshoff et 
al., 2015; Leach et al., 2019; Martin et al., 2015; Mijwel et al., 2018; Paulo et al., 2018; Turner 
et al., 2004). Other studies have used resistance programs akin to the ACSM guidelines for 
muscular endurance (Lee, Kim, et al., 2018; Martin et al., 2015; Okumatsu et al., 2019; Paulo 
et al., 2018). 
 Measures of muscular strength and endurance involve one repetition maximum (1-RM) 
(in strength) and 10-RM (in endurance) tests, and statistically significant (p<0.05) increases 
have been found in these variables in both previously active and inactive breast cancer 
survivors after a combined exercise training program (Battaglini et al., 2007; De Luca et al., 
2016; Dieli-Conwright, Courneya, et al., 2018; Herrero et al., 2006; Leach et al., 2019; Lee, 
Kim, et al., 2018; Ortega & de Paz Fernández, 2016; Paulo et al., 2018; Schulz et al., 2018; 





Functional training programs emphasize the integration of movements recruiting 
multiple joints and muscle groups (Cress et al., 1996; Feito, Heinrich, Butcher, & Poston, 
2018). While isolation muscle training may be effective for rehabilitation areas, it does not 
train muscles to work cooperatively (Cress et al., 1996). Functional training provides 
integration of body systems and muscle groups and can be more effective at improving 
functional fitness than regular aerobic or resistance training (Crawford et al., 2018; Cress et al., 
1996; De Vreede et al., 2005; Haddock, Poston, Heinrich, Jahnke, & Jitnarin, 2016; Sperlich 
et al., 2017).  
High intensity functional (HIFT) training is a relatively novel exercise modality, and 
little research has been done around its effectiveness in clinical populations. Drawing 
inspiration from HIIT, HIFT aims to provide functional benefits to the quality of life and 
disease risk of those that undertake this modality (Cress et al., 1996; De Vreede et al., 2005; 
Feito et al., 2018; Haddock et al., 2016; Heinrich et al., 2015). High intensity functional training 
incorporates the muscular strength and functional benefits of functional training, and the 
cardiorespiratory/vascular benefits of high intensity training to provide a multi-faceted exercise 
intervention (Crawford et al., 2018; De Vreede et al., 2005; Heinrich et al., 2015; Heinrich et 
al., 2014; Pacheco et al., 2013).  
Feito et al. (2018) established a working definition of HIFT after evaluating the 
literature, interpreting that HIFT is: “a training style [or program] that incorporates functional, 
multimodal movements, performed at relatively high intensity, and designed to improve 
parameters of general physical fitness and performance” (page 13). High intensity functional 
training began as a training modality among populations such as military and fire services, with 
Heinrich et al. (2014) among the first to investigate its use among non-military and service 




more likely to be continued than sole aerobic or resistance focused programs (Heinrich et al., 
2014). Examples of multi-joint, functional movements include lunges with a dumbbell press 
or squats with a bicep curl. Functional exercise programs should include exercises that 
incorporate the three fundamental movement planes (frontal, sagittal and rotational) (Feito et 
al., 2018; Winters-Stone et al., 2012). 
Early studies of HIFT have suggested similar benefits in cardiorespiratory and body 
composition measures as those observed in HIIT interventions (Crawford et al., 2018; Haddock 
et al., 2016; Sperlich et al., 2017), and as good or greater muscular strength, balance and 
functionality benefits than those observed from resistance training interventions (De Vreede et 
al., 2005; Pacheco et al., 2013). Functional training in military populations has shown to pose 
similar or lower risk of injury, while providing similar or greater gains in fitness and body 
composition, when compared with regular physical training (Haddock et al., 2016; Poston et 
al., 2016). Its use in clinical populations has only recently begun to be investigated. Heinrich 
et al. (2015) found significant improvements in body composition, functional movement and 
emotional functioning after 5-weeks of HIFT in breast cancer survivors, while Artese et al. 
(2021) found no effect on body composition with functional impact training. A novel exercise 
method, there is a need for increased research into this modality. 
Exercise among breast cancer survivors aids in recovery from treatment and can 
provide long-term benefits surpassing that of just cancer rehabilitation. All-cause mortality, 
CVD and recurrence risk are associated long-term side-effects of cancer treatment and their 
risks can be attenuated through exercise and physical activity (Adams et al., 2017; Gibala et 
al., 2012; Lee et al., 2010; McKenzie, 2012; Nystoriak & Bhatnagar, 2018; Stocci et al., 2007). 
Aerobic, resistance, combined and functional training can provide cardiovascular, 
cardiorespiratory and anthropometric benefits (Anderson et al., 2012; Battaglini et al., 2007; 




Dieli-Conwright, Courneya, et al., 2018; Dolan et al., 2016; Dolan et al., 2018; Herrero et al., 
2006; Kampshoff et al., 2015; Winters-Stone et al., 2012). The effects of HIFT in clinical 
populations, in particular breast cancer survivors, are less documented than those of aerobic, 
resistance or combination training, but early findings suggest its effectiveness as a training 
modality. 
Conclusion 
Cancer treatment can leave both acute and chronic negative effects on the 
cardiovascular and cardiorespiratory systems, as well as body composition (Armanious et al., 
2018; Bradshaw et al., 2016; Demark-Wahnefried et al., 2001; Freedman et al., 2004; Gernaat 
et al., 2017; Hooning et al., 2007; Jones et al., 2014; Klassen et al., 2014; Park et al., 2017; 
Peel et al., 2009; Raptopoulos & Constantinou, 2020; Yu & Jones, 2016). Exercise provides 
an effective way to reduce these negative-side effects. Increases in cardiorespiratory and 
cardiovascular fitness through aerobic, resistance, combined or functional training approaches 
attenuate these negative effects in both breast cancer patients and survivors (Bird & Hawley, 
2016; Brenner & Eisenberg, 1987; Cipryan et al., 2017; Cress et al., 1996; Kneis et al., 2016; 
Owens et al., 2019; Sardeli et al., 2017; Stocci et al., 2007; Visovsky, 2006). Improvements in 
muscular strength and endurance as well as body composition also aid in improving long-term 
outcomes, including recurrence risk and all-cause mortality (Battaglini et al., 2007; Demark-
Wahnefried et al., 2001; Dolan et al., 2010; Freedman et al., 2004; Irwin et al., 2008; Kim et 
al., 2019; Loprinzi & Cardinal, 2012; Mazzuca et al., 2018; Raptopoulos & Constantinou, 
2020; Stocci et al., 2007; Visovsky, 2006). Overall, exercise, whether prescribed as aerobic, 
resistance, combined or functional, and undertaken at moderate or high intensity, is safe and 
effective at increasing physical fitness, health and quality of life among breast cancer patients 











The purpose of this study was to determine the effect of a 20-week HIFT circuit 
program on functional, cardiorespiratory, muscle strength, and body composition variables. 
Twenty-five women were recruited into the study, with twenty undertaking the exercise 
intervention and five enlisted as controls. 
 Participants undertook a 30-minute, 12-station circuit-based exercise program twice a 
week for 20-weeks. Exercise stations involved aerobic (n = 4) and resistance (n = 8) exercise. 
The resistance exercise stations included two or three resistance exercises that participants 
alternated between for the duration of the station (i.e., 10 repetitions of kettlebell swings, 10 
repetitions squats, 10 repetitions of kettlebell swings etc.). Written, informed consent was 
obtained prior to testing (Appendix A). Ethical approval was granted by the University of 
Otago Human Ethics Committee (Health, H18/029). 
Participants completed a series of tests prior to, and after the exercise intervention. 
Testing was separated into two sessions, one involving functional, muscle strength and body 
composition tests and the other involved cardiorespiratory testing. Muscle strength and 
functional testing included a 1-RM bench press, handgrip strength, leg extension and flexion 
strength, balance tests, two functional movement tests (lift and carry and weighted stair climb) 
and a bio-impedance analysis (BIA) test, while cardiorespiratory testing included V̇O2peak tests, 
as well as measures of resting blood pressure and heart rate. 
Participants 
Twenty-five participants were recruited from the Exercise Training Beyond Breast 
Cancer (ExPinkTTM) program at the University of Otago School of Physical Education, Sport 




program or had completed the program and since left. All participants were classified as 
physically active (defined as attending the clinic at least twice weekly, or at least 60-minutes 
of moderate/vigorous intensity activity per week). Five participants withdrew from the study. 
Reasons for withdrawal included reconstruction surgery (n=2), unrelated health 
problems/illness (n=2) and work commitments preventing participation in the provided circuit 
times (n=1). In total, 20 completed the study, 16 HIFT participants and 4 controls 
Participant inclusion criteria included women aged between 37-62 years, diagnosed 
with primary breast cancer and had completed primary treatment, including chemotherapy 
and/or radiation therapy at least 6-months prior to beginning the study. 
Exclusion criteria for the study included recurrent breast cancer, distant metastases, 
diagnosed cardiovascular or peripheral vascular disease, major joint injury or diabetes mellitus, 
having had surgery only for primary breast cancer treatment, or are currently taking medication 
that may alter vascular function. 
For the duration of the study, participants were asked to record exercise undertaken 
outside of the intervention, filling out a 7-day self-administered short version of the 
International Physical Activity Questionnaire (IPAQ) each week. Participants were not asked 
to limit or alter exercise outside of the HIFT protocol, they were only asked that they recorded 
exercise that they did undertake. 
Control participants continued their normal exercise routine for the duration of the 
study, also completing the IPAQ questionnaire. Controls were not asked to alter their physical 
activity at all; however, they were asked to record any physical activity undertaken. 
Strength tests 
Upper and lower body strength was assessed using 1-RM tests, with these tests being 
familiar to the participants as they are undertaken as a part of the ExPinkTTM program. Upper 




press tests, while lower body tests used a Biodex dynamometer (BIODEX System 2, 900-800, 
USA) to assess maximal leg extension and flexion strength. Handgrip testing involved 
participants squeezing the handgrip dynamometer as hard as possible and was repeated three 
times on each hand, with the highest value for each hand used as the result. For 1-RM bench 
press testing, participants lay on a bench and completed a warmup set of 10 reps of the bar 
(7.5kg), after which weight was progressively added to the bar and one repetition was 
completed, until voluntary maximum was reached. Weight progressions were individualised to 
each participant. The test aimed at reaching 1-RM within 5-6 attempts. Maximal lower body 
strength testing using the Biodex had participants strapped into the machine and measured 
maximal knee extension and flexion force of the right leg. Three repetitions were performed, 
and maximum effort for flexion and extension was recorded. 
Physical function test 
Seven physical function tests were undertaken incorporating balance and functional 
movement. After completing each test, participants were asked to rate the difficulty of the task 
from 1 (easy) to 10 (difficult). The seven tests were: three two leg balance tests (feet side-by-
side, feet in split stance, feet heel-to-toe), single leg balance, a star balance excursion, a lift-
and-carry test and a weighted stair climb (Heyawrd & Gibson, 2014). 
Balance testing was undertaken for both static and dynamic balance. Static balance 
testing involved participants balancing at each foot stance until either balance was lost, or 45-
seconds passed. Single legged balance was undertaken on the left leg. The star balance 
excursion test is a measure of dynamic balance, and required participants to balance on the left 
leg, and maximally reaching the right leg out in four directions (forwards, backwards, medially, 
and laterally) (Heyawrd & Gibson, 2014). Distance reached was then compared relative to leg 




Functional movement testing was done through two tests; a lift and carry test and a 
weighted stair climb (Heyawrd & Gibson, 2014). The lift and carry test involved participants 
walking 3-meters from a start cone to a bench, where they picked a 5kg weight up off the 
ground, carried the weight around the bench back to the start point, then returned to place the 
weight on top of the bench and returned to the start (Heyawrd & Gibson, 2014). For the 
weighted stair climb test, participants picked a 5kg weight up off the ground, and 
climbed/descended a flight of 10 steps, three times sequentially, before placing the weight back 
on the ground upon completion of the third flight (Heyawrd & Gibson, 2014). For both 
functional tests, participants were timed and upon completion, asked to rate the test on 
difficulty from 1-10. All weight carrying for the functional tests was done in the non-dominant 
hand. 
Cardiorespiratory fitness tests 
Cardiorespiratory testing consisted of a maximal cardiorespiratory exercise test. 
Resting heart rate and blood pressure measures were also taken. Respiratory variables were 
measured using a metabolic cart (COSMED Quark, Italy). Preparation of the metabolic cart 
included gas analysis to a standard calibration gas mixture and room air. Calibration of the 
turbine was done using 3000mL syringe. At the beginning of each CRF testing session 
participants were asked to sit quietly for five minutes, after which resting blood pressure and 
heart rate measures were taken using a digital automatic blood pressure monitor (Omron, 
Japan). 
Maximal cardiorespiratory exercise testing was undertaken on a Velotron 
electromagnetically braked cycle ergometer (RacermateTM, Seattle, WA) using a step protocol 
until volitional exhaustion. Prior to the initiation of the cycle test, seat height and handlebar 
position were adjusted to participant’s preference, and a heart rate monitor (Polar, Finland) was 




The incremental cycle test consisted of participants pedalling against an initial workload of 50-
75W for 2-minutes, which was then incrementally increased by 15-30W every 2-minutes until 
the participant was unable to continue. Initial workload and incremental increases were tailored 
to each participant with the aim of reaching voluntary exhaustion in 8-12 minutes. Heart rate 
and RPE were taken at the end of each stage. Workload increments were determined by the 
researcher, with three things considered: heart rate, RPE and cadence. Each test was completed 
in the University of Otago School of Physical Education, Sport and Exercise Sciences, 
Dunedin, New Zealand. The same gas analysis system was used for all tests. Variables analysed 
from the cardiorespiratory testing were V̇O2peak and HRmax. Oxygen consumption was averaged 
over 10-second periods and peak oxygen consumption (V̇O2peak) was the highest average V̇O2 
from two consecutive 10s periods, within the final two minutes, achieved during the test. HRmax 
was taken from the heart rate achieved at V̇O2peak. 
Intervention 
Participants attended circuit sessions twice-weekly over a 20-week period, with the aim 
of attending a total of 40 sessions. Each session consisted of a 5-10-minute warm-up, 30-
minutes of the circuit, and a 5-10-minute cooldown. Stations were numbered 1-12, and 
participants could start wherever, however they followed each station sequentially (i.e., start at 
6, move to 7, 8, 9… end at station 5). The initial week of the exercise sessions consisted of 
teaching participants the exercises and order or the circuit, to ensure exercises were performed 
safely with correct technique. The 20-week period was broken up into four, five-week blocks, 
where upon the completion of each block, circuit stations were changed. Each circuit block 
consisted of four cardio stations (i.e., treadmill, exercycle, cross-trainer, rower) and eight 
combined-exercise stations. Stations were set up in order of one cardio, followed by two 
resistance, i.e., stations one, four, seven and ten were cardio, with the rest being resistance. 




to rest and move from station to station. Exercises used in circuit blocks are available in 
Appendix C. The order circuits were set up in was catered to the confines of the gym (i.e., 
exercises using machines were undertaken where the machines were, while stations using body 
weight and dumbbell exercises were set up anywhere in the gym). Where necessary, circuits 
were personalised to cater for any changes required to exercise movements (i.e., participants 
who had had a TRAM flap reconstruction unable to undertake core movements in the sagittal 
plane). 
Four times during the exercise intervention, participants wore a heart rate monitor 
(Polar, M400, Finland) for the duration of the circuit in order to determine exercise intensity 
(% of maximum recorded heart rate from the initial V̇O2peak test). 
Statistical analysis 
Independent t-tests were used to compare baseline measures of age, height, and time 
since treatment completion between those in the intervention group and controls. Cancer stage 
and treatments were presented as frequencies and percentage of groups. A two-way repeated 
measures ANOVA was undertaken using baseline and final data to compare the mean 
differences between the groups to assess the effect of 20-weeks of HIFT on functional fitness, 
muscle strength, body composition and CRF. All analyses were undertaken using the statistical 






Twenty physically active female breast cancer survivors volunteered to participate in 
the study. A further five volunteered as controls. Baseline characteristics for both groups are 
presented in Table 1. 
Overall, five participants withdrew from the study. In the HIFT intervention group, one 
participant withdrew due to breast reconstruction surgery, one due to adverse health conditions, 
one due to other illness, and one due to work commitments. One participant in the control 
group withdrew due to breast reconstruction surgery. The 16 participants who completed the 
HIFT intervention completed all 40 sessions. Table 2 summarizes functional test results, while 
table 3 is comprised of muscle strength, body composition and cardiorespiratory results. 
Functional measurements 
 Lift and carry test time decreased in the intervention group, but not in the control group. 
There was a significant main effect for time (=.017); however, there was no significant between 
group effect between the HIFT participants and controls (p=.510). There was a significant 
interaction effect between the groups and the length of the intervention, (p=.010). 
There was a significant effect on time to complete weighted stair climb test over the 
length of the intervention (p=.012) with time taken to complete the test decreasing in both the 
HIFT and control group. However there was no main between group effect (p=.754). No 
significant interaction effect was observed between groups and the length of the intervention 
(p=.132). 
 No significant main effect for time was observed for the star-balance-anterior reach 
(p=.926), nor between the intervention and control groups (p=.465), nor was there a significant 




There was a significant main effect of time for increases in the star-balance-posterior 
reach (p=.014), with increases seen in both the HIFT and the control groups. There was no 
significant between group effect (p=.594), nor was there a significant interaction effect 
observed between the groups and the length of the intervention (p=.066). 
 No significant effect was observed for the star-balance-medial reach over time 
(p=.133), nor between groups (p=.654). No significant interaction effect was observed between 
groups and the length of the intervention (p=.846). 
 No significant effect for time was found for the star-balance-lateral test (p=.607), nor 
between groups (p= .996). No significant interaction effect was observed between groups and 
the length of the intervention (p=.171) 
 Muscle strength variables 
 No significant main effect for time was observed for 1-RM bench press (p=.538), nor 
was there significant differences seen between groups (p=.862). No significant interaction 
effect was observed between groups and the length of the intervention (p=.134). 
 Knee extension strength increased over time in both the HIFT and control groups, with 
a significant main effect for time observed (p=.007). There was no significant effect between 
groups (p=.524), nor was there a significant interaction effect observed between the groups and 
the length of the intervention (p=.525). 
 Knee flexion strength increased over time in both the HIFT and control groups, with a 
significant main effect for time observed (p=.027). No significant main effect was found 
between the intervention and controls (p=.358), nor between the groups and the duration of the 
study (p= 388). 
Left handgrip strength saw no significant main effect for time (p=.421), nor between 
groups (p=.556). No significant interaction effect was observed between groups and the length 




 No significant main effect for right handgrip strength was found for time (p=.855), nor 
for group (p=.556). No significant interaction effect was observed between groups and the 
length of the intervention (p=.978). 
 Cardiorespiratory variables 
 No main effect for V̇O2peak was found for time (p=.324), or between group (p=.705). 
No significant interaction effect was observed between groups and the length of the 
intervention (p=.530). 
 Systolic blood pressure decreased over time in both the HIFT and control groups, with 
a significant main effect for time observed (p=.012). Systolic blood pressure in both groups 
decreased, with a greater decrease in the control group. No main effect was found between the 
groups (p=.279), nor was there a significant interaction effect observed between the groups and 
the length of the intervention (p=.091). 
 No significant effect for time was seen in diastolic blood pressure (p=.322), nor 
between groups (p=.239). No significant interaction effect was observed between groups and 
the length of the intervention (p=.450). 
No main effect for peak heart rate was found for time (p=.284), or between groups 
(p=.929). No significant interaction effect was observed between groups and the length of the 
intervention (p=.786). 
Body composition variables 
No significant effect for time was observed for body weight (p=.362), nor between the 
groups (p=.795). No significant interaction effect was observed between groups and the length 
of the intervention (p=.484). 
No significant effect for time was observed for lean muscle mass (p=.613), nor between 
groups (p=.941). No significant interaction effect was observed between groups and the length 




No significant effect for time was observed for fat mass (p=.757), nor between the 
groups (p=.675). No significant interaction effect was observed between groups and the length 
of the intervention (p=.097) 
No significant main effect for time was observed for fat free mass, (p=.465), nor 
between groups (p=.951). No significant interaction effect was observed between groups and 
the length of the intervention (p=.130). 
No significant main effect for time observed for BMI (p=.351), nor between groups 
(p=.844). No significant interaction effect was found between the groups and the duration of 
the intervention (p=.554). 
No significant main effect for time was observed for body fat percentage (p=.946), 
nor between groups (p=.730). No significant interaction effect was observed between groups 





Table 1. Baseline data (mean, SD) and cancer stage, treatment and treatment status (number, 











Height (SD) cm 166 (6.8) 165(6.5) 
Stage (n, %)   
0 1 (5) 0 (0) 
IA 4 (20) 1 (20) 
IIA 9 (45) 2 (40) 
IIB 3 (15) 2 (40) 
IIIA 2 (10) 0 (0) 
IIIC 1 (5) 0 (0) 
Treatment (n, %)   
Chemotherapy 16 (80) 4 (80) 
No Chemotherapy  4 (20) 1 (20) 
Radiation 15 (75) 4 (80) 
No radiation 5 (25) 1 (20) 
Herceptin 5 (25) 1 (20) 
No Herceptin 15 (75) 4 (80) 
Tamoxifen 9 (45) 2 (40) 
No Tamoxifen 11 (55) 3 (60) 
Aromatase Inhibitor 2 (10) 0 (0) 
No Aromatase Inhibitor 18 (90) 0 (0) 
Time since treatment completion 
(months, SD) 
68 (70) 14 (7) 
 





Table 2. Pre- and post-intervention functional test data for HIFT and control groups 
 







Variable HIFT (Group 1) CONTROL (Group 2)  P value  
 Pre Post Pre Post Time Group Interaction 
Functional tests        
Carry tests (seconds/rating 
out of 10) 
       
Lift and carry 14.65s/1 12.58s/1 14.29s/1 14.38s/1 .017* .941 .010* 
Weighted stair climb 32.98s/2.13 30.03s/1.06 31.09s/1.75 30.27s/1 .012* .675 .132 
Leg reach (% of leg length)        
Anterior 80.68 ± 13.4 82.62 ± 13.6 87.69 ± 4.4 85.11 ± 12.7 .926 .456 .514 
Posterior 81.69 ± 15.7 99.88 ± 14.9 93.19 ± 11.7 96.10 ± 7.4 .014* .594 .066 
Medial 84.02 ± 13.8 88.84 ± 14.9 86.41 ± 9.3 92.60 ± 9.1 .133 .654 .846 
Lateral 66.60 ± 20.6 69.86 ± 15.7 71.71 ± 8.8 64.67 ± 18.6 .607 .795 .171 
Balance (seconds/rating 
out of 10) 
    
   
Side-by-side 45/1.06 45/1.0 45/1.0 45/1.0 - - - 
Split stance 45/1.16 45/1.25 45/1.75 45/1.75 - - - 
Heel-to-toe  45/2.78 45/2.89 45/3.25 45/4.0 - - - 






Table 3. Pre- and post-intervention muscle strength, body composition and cardiorespiratory data for HIFT and control groups 
 
HIFT = high intensity functional training; BMI = body mass index; BP = blood pressure; * = statistically significant at p<0.05
Variable HIFT (Group 1) CONTROL (Group 2)  P value  
 Pre Post Pre Post Time Group Interaction 
Muscle strength        
Thigh strength (Biodex 
extension) (Nm) 95.32 ± 23.1 106.27 ± 20.9 104.91 ± 22.2 111.99 ± 17.5 
.007* .524 .525 
Hamstring strength (Biodex 
flexion) (Nm) 70.72 ± 14.6 73.20 ± 11.5 76.50 ± 16.3 81.89 ± 19.3 .027* .358 .388 
Bench Press (Kg) 30.52 ± 6.7 31.98 ± 7.0 32.23 ± 6.4 31.60 ± 7.7 .538 .862 .134 
Grip strength right (Kg) 30.99 ± 6.0 31.16 ± 5.7 34.80 ± 9.3 34.93 ± 7.1 .855 .287 .978 
Grip strength left (Kg) 28.54 ± 5.9 28.52 ± 5.9 31.13 ± 7.7 29.85 ± 5.0 .421 .566 .438 
Body composition        
Weight (Kg) 70.15 ± 14.7 70.25 ± 14.6 67.70 ± 13.1 68.45 ± 13.5 .362 .951 .484 
Muscle mass (Kg) 25.19 ± 4.1 25.69 ± 4.1 25.75 ± 4.1 25.48 ± 4.3 .613 .844 .099 
Fat mass (Kg) 24.30 ± 10.5 23.57 ± 10.5 21.05 ± 6.8 22.10 ± 6.6 .757 .730 .097 
Fat free mass (Kg) 45.85 ± 6.8 46.68 ± 6.8 46.65 ± 6.6 46.35 ± 7.2 .465 .705 .130 
BMI (Kg/m2) 25.91 ± 5.2 25.98 ± 5.2 25.25 ± 3.9 25.53 ± 4.2 .351 .844 .544 
Body fat percentage (%) 33.40 ± 9.1 32.26 ± 9.3 30.55 ± 4.4 31.78 ± 4.0 .946 .730 .063 
Cardiorespiratory        
V̇O2peak (mL/kg/min) 29.50 ± 4.8 29.72 + 5.0 28.12 ± 5.2 29.10 ± 3.3 .324 .705 .530 
Systolic BP (mmHg) 129.88 ± 18.2 126.37 ± 19.8 125.75 ± 5.7 110.0 ± 6.4 .012* .279 .091 
Diastolic BP (mmHg) 73.00 ± 11.1 72.31 ± 11.6 68.75 ± 3.6 63.75 ± 7.4 .322 .239 .450 






 Breast cancer treatments can lead to adverse changes in functional, cardiorespiratory 
and cardiovascular fitness and body composition (Armanious et al., 2018; Bradshaw et al., 
2016; Demark-Wahnefried et al., 2001; Freedman et al., 2004; Gernaat et al., 2017; Hooning 
et al., 2007; Jones et al., 2014; Klassen et al., 2014; Park et al., 2017; Peel et al., 2009; 
Raptopoulos & Constantinou, 2020; Yu & Jones, 2016). Decreases in CRF may worsen 
prognosis and survival rate among breast cancer patients (Peel et al., 2009). Evidence shows 
that exercise training of any modality; aerobic, resistance, combined or functional, are all 
effecting at improving facets of fitness and body composition in breast cancer populations 
(Anderson et al., 2012; Armanious et al., 2018; De Vreede et al., 2005; Lite & Mejia, 2010; 
Mijwel et al., 2018; Raptopoulos & Constantinou, 2020; Yu & Jones, 2016). The purpose of 
this study was to observe the effect of a 20-week HIFT program on muscle strength, functional 
fitness, body composition and cardiorespiratory variables in recreationally active breast cancer 
survivors. The main findings of this study were that HIFT provides significant increases in 
functional fitness, including weighted carry tests and posterior leg reach, as well as increases 
in lower limb strength and systolic blood pressure. While not significant, there was a trend of 
favourable body composition variables in the HIFT group compared to the controls, while no 
significant effect was seen on upper body strength or CRF. Participants already attended 
ExPinkTTM twice weekly, so twice weekly sessions of the HIFT intervention mirrored that of 
their regular gym routines. The twice weekly HIFT in the intervention also mirrored the twice 
weekly combined sessions undertaken by the controls who continued their regular attendance 
of the ExPinkTTM clinic. External physical activity reported through IPAQ questionnaires 





Lift and carry test 
The HIFT intervention reduced lift and carry test time (-14.2%) compared to a 0.6% 
increase in the control group, significant over time (p=0.17), with no significant difference 
between groups (p=.941). There was a statistically significant time by group interaction found 
for lift and carry test time (p=.010). Changes associated with the HIFT group are consistent 
with those induced in a study by Heinrich et al. (2015) where 5-weeks of thrice-weekly HIFT 
in breast cancer survivors found a 19.2% reduction in lift and carry test time (p=0.004). Due to 
the significant interaction effect, it cannot be established whether the reduction in lift and carry 
time in the current study was caused by the length of the intervention or the mode of training. 
There is an inverse relationship between time to complete the lift and carry test and capacity 
for ADLs, with increased ADL capacity associated with an improvement in quality of life (Jette 
et al., 1990; Wasserman et al., 2011). 
Weighted stair climb 
 There was a significant reduction (p=.012) in weighted stair climb test time in both 
groups with decreases of 9.0% and 2.6% in the HIFT and control groups respectively. Although 
the intervention group decreased test time 3.6 times more than the intervention group, there 
was no statistically significant differences between the intervention and control group (p=.675). 
This reduction, while slightly lower than that induced in Heinrich et al. (2015) (-15.1%, 
p=0.002), are still a significant decrease in time to complete. 
 Functional carrying tests provide indications of participants ability to undertake ADLs. 
The tests undertaken in the current study mimic ADLs such as carrying groceries, climbing 
stairs and general mobility. Changes induced with the HIFT intervention indicate that this 





 No changes were observed in balance tests, with both intervention and control groups 
recording maximum time scores in all but one balance test undertaken (319/320). Both groups 
excelled at the balance tests, suggesting the tests used may have been too simple for the 
participants. Insignificant changes were recorded in RPE difficulty rating, with patients 
familiarity with the rating scale possibly influencing results. 
 Heinrich et al. (2015) observed a 50.2% increase in single-leg balance time, and a 5.3% 
reduction in difficulty rating of the test after a 5-week HIFT program in breast cancer survivors. 
Unlike the current study, there was no cap on time, therefore increases were able to be achieved. 
In the current study, alternate balance tests could have been used to detect changes in balance 
with the HIFT intervention. These tests include eyes-closed balance tests, using similar foot 
stances as undertaken in the current study, increasing the difficulty of balancing. Alternatively, 
participants could have balanced on a bosu ball or balance board, which may have provided 
more challenge. 
Star balance excursion 
 The star balance excursion test showed a significant increase in posterior leg reach, 
with no significant changes seen in anterior, medial, and lateral reaches. In the HIFT group, 
posterior reach increased 18.2%, while anterior, medial and lateral showed non-significant 
increases of 2.35%, 5.42% and 4.66% respectively. The control group had changes of -3.04%, 
3.03%, 6.69% and -10.89% in the anterior, posterior, medial and lateral reaches respectively. 
In the HIFT group, posterior reach was the only reach to show significant increases, however 
average changes were all positive, suggesting flexibility was increased in all directions. 
Functional testing mimicked ADLs, such as carrying groceries or items around the 
house, balance and flexibility, with improvements in these tests providing benefits to 




provide insight into the effect of the HIFT intervention on flexibility and balance of the 
participants. While there was improvements in the star balance excursion test, in both pre- and 
post-study balance tests maximum scores were achieved on all balance tests, bar one pre-test 
single-legged balance, therefore no improvement was able to be shown. This suggests that a 
more difficult balance test should have been undertaken with capacity for improvements. No 
significant changes were shown in the RPE’s of the balance tests from pre- to post-tests, with 
participants familiarity with the test possibly inhibiting its effectiveness, with scores on the 




All measures of leg strength increased in both groups, with no significant difference 
between the HIFT and control groups. Thigh extension force increased 11.5% and 6.8% in the 
HIFT and control groups respectively (p=.007). Similarly, thigh flexion force increased in both 
groups, with increases of 3.5% and 7.1% in the HIFT and control groups respectively (p=.027). 
No significant difference was observed between groups (p>0.05). Results from the leg strength 
tests demonstrate that HIFT, like the controls regular exercise routine, can have a positive effect 
on lower limb strength in physically active breast cancer survivors. 
 The increases in leg extension and flexion strength are similar to those associated with 
functional training studies in both breast cancer and healthy populations. Artese et al. (2021) 
observed an 11.5% and 12% increase in flexion and extension forces respectively in breast 
cancer survivors. Comparative measures of lower body strength found in other HIFT studies 
have induced greater lower body strength increases measured using a sit-stand test (28.2%, 
p=0.009), squat-1-RM (9.8%, p<0.05) and leg press-5-RM (22.5%, <0.001%) (Brisebois, 




body strength (22.5% and 28.2%) were induced in HIFT interventions in unfit or inactive 
individuals (Brisebois et al., 2018; Heinrich et al., 2015). These changes induced in inactive 
individuals are larger than those induced in physically active, healthy individuals (9.8%), 
further suggesting that while HIFT has a larger effect on untrained individuals, significant 
improvements in lower limb strength can still occur in already active participants (Crawford et 
al., 2018). 
 Changes in leg extension and flexion strength in the current study are lower than those 
associated with combined exercise interventions. These programs induced significant (p<0.05, 
66.7% and 61.0%) and non-significant (p>0.05, 20.4% and 13.3%) changes in leg extension 
and flexion strengths respectively in breast cancer survivors partaking in 16-24 week 
intervention programs with two to three sessions per week (De Luca et al., 2016; Dieli-
Conwright, Courneya, et al., 2018). Increases in leg extension strength in the current study 
differ from a non-significant decrease in a 12-week, thrice-weekly resistance training 
intervention (-8.4%) (De Vreede et al., 2005). 
 Comparative measures of lower body strength in combined and resistance exercise 
programs have recorded both significant (p<0.05) and non-significant (p>0.05) increases in 
lower body strength (squat 1-RM, leg press 1-RM). Combined exercise interventions have 
induced lower body strength increases of 28.9% and 38.0% (Casla et al., 2015; Leach et al., 
2019), while resistance training interventions have induced non-significant increases from 
19.4% - 27.4% and significant increases from 26.3% - 46.0% (Brown & Schmitz, 2015; 
Hagstrom et al., 2016; Santos et al., 2019; Schmitz et al., 2009; Winters-Stone et al., 2012). 
Combined exercise interventions ranged from 8-to-12-weeks, with participants exercising two 
to three times per week (Casla et al., 2015; Leach et al., 2019). Resistance exercise 




three times a week (Brown & Schmitz, 2015; Hagstrom et al., 2016; Santos et al., 2019; 
Schmitz et al., 2009; Winters-Stone et al., 2012). 
Many combined and resistance programs employed resistance exercise prescriptions 
akin to ACSM guidelines for increasing muscular strength, hence the larger increases in muscle 
strength associated with these studies (Brown & Schmitz, 2015; De Luca et al., 2016; De 
Vreede et al., 2005; Dieli-Conwright, Courneya, et al., 2018; Hagstrom et al., 2016; Santos et 
al., 2019; Schmitz et al., 2009). While lower than results recorded in the literature, increases in 
the current study show that HIFT, similar to the controls regular exercise program, can provide 
significant increases in leg extension and flexion strength. Increases in muscle strength are 
important for increasing capacity for ADLs and effective at reducing adverse events such as 
falls. Further increases in leg extension in flexion strength may have been caused had the HIFT 
program undertaken exercises more directly related to the Biodex leg strength tests undertaken 
(i.e. leg extension and flexion machines included in the circuit stations). While lower limb 
strengthening exercises were included in the circuits (i.e. squats, deadlifts, kettlebell swings), 
movement patterns were different to the seated leg flexion and extension undertaken in muscle 
strength testing. 
Bench press 
 No statistically significant change (p>0.05) was observed for bench press 1-RM in 
either the HIFT or control group despite a +5.1% and -2.5% respectively. Improvements in 
comparative measures of upper body strength associated with functional training interventions 
with both inactive individuals and breast cancer survivors have caused changes ranging from 
13.7% to 19.2% (p<0.05) (Artese et al., 2021; Brisebois et al., 2018). These changes are larger 
than those associated with the current study, however measures were either indirect measures 
of bench press through a resistance machine (Artese et al., 2021) or were induced in inactive, 




 A 12-week, twice weekly combined exercise intervention in breast cancer survivors 
induced a 35.4% increase in predicted bench press 1-RM. Predicted bench press is less accurate 
than direct measurements undertaken in the current study, therefore reported changes may be 
different than strength increases that actually occurred. However, significant changes in upper 
body strength were still observed (Artese et al., 2021). 
 Results of the current study are lower than those in resistance training interventions, 
with significant (p<0.05) increases of 12.5% to 26.2% in 12-month interventions where 
participants exercised two to three times per week (Brown & Schmitz, 2015; Winters-Stone et 
al., 2012). Non-significant (p>0.05) changes induced in resistance intervention studies are also 
higher than those in the current study, with increases of 23.1% and 25.0% in 1- and 10-RM 
respectively (Santos et al., 2019; Schmitz et al., 2009). While increases in strength in the 
current study are lower than those in the literature, initial 1-RM was lower in all four previous 
studies than our cohort (19.1kg - 25.5kg compared to 30.5kg). Higher initial 1-RM in the 
participants in the current study may have hindered their ability to further increase upper body 
strength, potentially plateauing. Resistance intervention studies specifically targeted both 
resistance training guidelines for increasing muscle strength, and directly trained participants 
using bench press exercises. In the current intervention, bench press related exercises were only 
undertaken in two of the four exercise cycles (machine bench press, single-arm lying dumbbell 
bench press), and upper body strength was also increased through other exercises. In both 
interventions with significant results, the length of the intervention was longer than the current 
study (12-months versus 20-weeks), which may account for the larger increase induced, 
relative to the current study. 
 Increases in upper body strength can improve posture, improve ability to undertake 
ADLs and help regain muscle function losses associated with breast cancer treatment (Artese 




Refshauge, & Krupa, 2008). These benefits can improve quality of life among breast cancer 
survivors. Results of the current study suggest that HIFT can maintain a high level of upper 
body strength in physically active breast cancer survivors. 
Handgrip strength 
 There were no significant (p<0.05) changes in grip strength for either left or right hand, 
with right handgrip strength changes of +1.1% and +1.9%, and left handgrip strength changes 
of +0.3% and -2.6%, in intervention and control groups respectively. Results in the literature 
from functional, combined and resistance interventions have found varying non-significant 
changes in handgrip strength in breast cancer survivors and older women, ranging from -1.2% 
to + 6.1% (De Vreede et al., 2005; Kampshoff et al., 2015; Winters-Stone et al., 2012). 
Interventions ranged from 12-weeks to one year, exercising 2-3 times per week. Grip strength 
is a predictor of future disability among older adults, thus, clinical practitioners should be aware 
of reductions in patient grip strength (Bohannon, 1998).  
Anthropometry 
Body weight 
 There was no significant change in body weight over time in either group (p=.362), nor 
were there between group differences throughout the intervention (p=.951), with changes of 
0.2% and 1.1% seen in the intervention and control groups respectively. These insignificant 
results are similar to those from other functional and HIFT training studies in breast cancer 
survivors and older women (-1.9% - +0.4%) (Artese et al., 2021; Cress et al., 1996; Heinrich 
et al., 2015). However, Sperlich et al. (2017) found a significant (p<0.05) decrease of 2.5% 
body weight after a 9-week, thrice-weekly HIFT intervention in overweight women (average 
BMI = 28.1 kg/m2 compared to this studies 25.9 kg/m2). Possible reasons for the notable 





 Combined training interventions are associated with various effects on body weight. 
Significant changes (p<0.05) range from -0.8% to -3.7%, in interventions ranging from 16-22 
weeks, from once to thrice weekly sessions (Dieli-Conwright, Parmentier, et al., 2018; Dolan 
et al., 2018). Non-significant (p>0.05) changes in body weight of +0.3% to -2.3% are 
associated with interventions ranging from 8-weeks to 12-months, and once to thrice weekly 
sessions (Casla et al., 2015; Courneya et al., 2003; Herrero et al., 2006; Nuri et al., 2012; Ortega 
& de Paz Fernández, 2016; Pinto, Clark, Maruyama, & Feder, 2003; Thomas et al., 2017). 
Shorter interventions (8-weeks, once or twice weekly) are associated with changes from -1.0% 
to +1.0%, while longer interventions (12-months, twice weekly) are associated with changes 
from -2.3% to -2.9% (Benton & Schlairet, 2017; Brown & Schmitz, 2015; Santos et al., 2019; 
Schmitz et al., 2009). Body weight changes from the current study sit within the realm of those 
induced in other exercise interventions, with the exception the larger reductions associated with 
longer duration resistance programs. 
 Aerobic interventions have induced varying significant (p<0.05) and non-significant 
(p>0.05) reductions in body mass. Interventions that induced significant results ranged from 
22- to 26-weeks, exercising one- to three-times per week (Dolan et al., 2016; Segal et al., 2001) 
while interventions associated with non-significant changes ranged from 10- to 22-weeks, 
exercising one- to three-times per week (Burnham & Wilcox, 2002; Dolan et al., 2016; 
Murtezani et al., 2014). Aerobic exercise interventions incorporated either moderate intensity 
continuous training or HIFT.  
 Body mass changes are influenced by lean tissue and fat mass, with gains in body 
weight not necessarily unhealthy if lean tissue increases outweigh losses in fat mass. Exercise 
is a small component of weight loss, with body weight reduction requiring a caloric deficit, 




study, like other exercise interventions in breast cancer survivors, had no dietary restrictions or 
alterations, as weight loss was not a primary outcome goal of the intervention.  
Lean body mass 
 No statistically significant changes (p>0.05) were induced in lean mass over time or 
between the groups, with a 2.1% increase in the HIFT group and a 1.2% decrease in the control. 
Other functional studies in both inactive adults and breast cancer survivors are associated with 
both significant (p<0.05) increases of 2.2% to 7.7%, and non-significant increases of 0.7% 
(Artese et al., 2021; Brisebois et al., 2018; Heinrich et al., 2015). Combined exercise programs 
have induced significant (p<0.05) increases in lean body mass of 0.3% to 4.4% in interventions 
ranging from 8-weeks to 12-months and two to three times weekly sessions, with the exception 
of An et al. (2020), inducing a reduction of 1.9% (An et al., 2020; Battaglini et al., 2007; Casla 
et al., 2015; Dieli-Conwright, Courneya, et al., 2018; Herrero et al., 2006; Thomas et al., 2017). 
Resistance training exercise programs in breast cancer survivors have found varying results in 
lean body mass, ranging from 1.8% to -2.4% in interventions ranging from 8-weeks to 12-
months, once or twice weekly (Brown & Schmitz, 2015; Santos et al., 2019; Schmitz et al., 
2009). An et al. (2020) induced non-significant (p>0.05) effects on lean body mass with 17-
weeks of twice-weekly high intensity (+0.8%) and moderate intensity (-0.7%) aerobic exercise 
respectively. 
 Due to the exercise program’s high intensity, weights used in resistance exercises may 
not have been high enough to induce muscle hypertrophy, hence the lack of significant 
increases in lean body mass. Lean body mass is important, particularly in older individuals, 
with low muscle mass a predictor of falls and overall poor health, and can lead to a reduced 





 No significant (p>0.05) changes in fat mass were induced, despite a decrease of 3.4% 
in the HIFT and an increase of 6.2% in the control group. While this is a large between group-
difference, due to the relatively small control group size (N = 4), this difference was not 
statistically significant. Fat mass results from the current study contrast those from Heinrich et 
al. (2015), who induced significant (p=0.001) reductions in fat mass (13.2%) with a 5-week 
HIFT intervention. The changes in the HIFT group are similar to other non-significant (p>0.05) 
results induced in other functional training studies in breast cancer survivors and overweight 
women, with decreases in fat mass of 2.1% and 4.8% (Artese et al., 2021; Sperlich et al., 2017). 
Changes associated with the current study are also similar to non-significant (p>0.05) changes 
caused from combined exercise interventions (-2.7% - -4.1%) (An et al., 2020; Thomas et al., 
2017) with the exception of Herrero et al. (2006), whose 8-week, thrice weekly combined 
training exercise intervention was associated with a non-significant (p>0.05) 10.4% reduction 
in body fat. Changes in the HIFT group were also lower than significant (p<0.05) changes of -
5.5% associated with a 16-week, thrice weekly combined exercise intervention (Dieli-
Conwright et al., 2018). Resistance exercise programs in breast cancer survivors are associated 
with non-significant changes in fat mass from -3.9% to +0.5% (Santos et al., 2019; Schmitz et 
al., 2009). Durations of resistance interventions lasted 8-13 weeks, exercising once to twice 
weekly.  
An et al. (2020) induced non-significant (p>0.05) increases of 8.4% and 12.8% in fat 
mass in aerobic interventions of either moderate intensity continuous or high intensity interval 
(HIIT) training in breast cancer patients undergoing chemotherapy. Participants undertook 
three aerobic exercise sessions per week during treatment, averaging 17-weeks duration. 




gains associated with chemotherapy are well documented, which may account for the increases 
in fat mass. (Sedjo et al., 2014; Van den Berg et al., 2017). 
With the increasing prevalence of long-term diseases among breast cancer survivors 
such as heart failure, diabetes and CHD, and their association with increased fat mass, reducing 
treatment-related weight gain is important for breast cancer survivors (Despres & Lemieux, 
2006; Feigelson et al., 2004; George et al., 2014; Irwin et al., 2005; Prineas et al., 1993; 
Schapira et al., 1994; White et al., 2015). While not significant, changes in fat mass in the 
current study suggest a trend of decreases in fat mass with a 20-week HIFT intervention. 
Fat free mass 
 No statistically significant (p<0.05) changes were induced in fat free mass over time 
(p=.465), with changes of 1.8% and -0.7% in the HIFT and control groups respectively. There 
were also no significant differences between groups (p=.705). These differences are slightly 
lower than significant (p<0.05) fat free mass changes associated with a 9-week, thrice weekly 
HIFT circuit among overweight women (3.4%) (Sperlich et al., 2017). Fat free mass in the 
current study incorporated all body components except fat, including body water, bone, organs 
and lean body mass. Due to the number of variable aspects that comprise fat free mass, 
particularly body water, FFM can fluctuate relatively easily, possibly hindering effectiveness 
of fat free mass as an outcome measure. However, BIA scans are not as sensitive as dual-energy 
X-ray absorptiometry (DXA) scans, so small changes were not detected.  
Body mass index 
No statistically significant (p<0.05) changes were induced for body mass index (BMI) 
over time (p=.351), or between groups (p=.844), with -0.3% and 1.0% changes associated with 
the HIFT and control groups respectively. Due to the already physically active nature of the 
participants, BMI results, alongside other body composition measures in the current study, are 




body mass. The average BMI’s of the participants was 25.9 and 25.3 kg/m2 in the intervention 
and control groups, respectively, classifying them in the early stages of overweight (ACSM et 
al., 2014).  
The lack of significant effects on BMI in the current study are similar to results in the 
literature. High intensity functional circuits are associated with both non-significant (+0.4%, 
p>0.05) and significant (-2.8%, p<0.05) changes in thrice weekly, five- and nine-week 
interventions respectively (Heinrich et al., 2015; Sperlich et al., 2017). Non-significant 
(p>0.05) changes induced in combined exercise interventions are associated with changes 
ranging from -2.4% to +0.8%, in interventions ranging from 8-22 weeks, exercising from once 
up to three times per week (Casla et al., 2015; Courneya et al., 2003; Daley et al., 2004; De 
Backer et al., 2007; Kampshoff et al., 2015; Nuri et al., 2012; Ortega & de Paz Fernández, 
2016). Thomas et al. (2017) induced a significant (p<0.05) decrease in BMI of 0.7% after a 12-
month, twice-weekly combined exercise intervention. Resistance programs are associated with 
varying non-significant (p<0.05) results in BMI, with changes ranging from -3.2% to +1.0% 
in interventions ranging from 8-weeks to 12-months, training once to twice a week (Benton & 
Schlairet, 2017; Brown & Schmitz, 2015; Santos et al., 2019; Schmitz et al., 2009). No 
significant impact on BMI has been induced in an aerobic intervention, with a reduction of 
3.1% after a ten-week, thrice-weekly aerobic training intervention (Murtezani et al., 2014). 
Similar to fat mass, higher BMI is associated with increased CVD risk. However, 
increases in BMI are not always unhealthy. Increases in lean body mass, when in the absence 
of or outweighing reductions in fat mass, increases BMI. Changes in BMI, akin to changes in 
body weight, are easier to interpret if body composition measures are also observed. The 
favourable body composition trends in the HIFT group in the current study show the possibility 




Body fat percentage 
 No statistically significant (p>0.05) changes were induced in body fat percentage over 
time (p=.946) or between groups (p=.730), with a decrease of 3.7% in the HIFT group and an 
increase of 4.7% in the control. While there was no significant change, due to the decreases in 
fat mass and increases in lean muscle mass in the HIFT and increases in fat mass and decreases 
in lean muscle mass in the control group, there was a trend of reduced body fat percentage in 
the HIFT group, and an increase in the control group. 
Changes in body fat percentage induced in the current study are similar to significant 
(p<0.05) reductions associated with other HIFT interventions, with reductions ranging from -
2.4% to - 14.2% (Brisebois et al., 2018; Heinrich et al., 2015; Nieuwoudt et al., 2017; Sobrero 
et al., 2015). Interventions ranged from five- to eight-weeks and all had participants exercising 
three times per week. Populations in these studies varied from cancer survivors, type 2 
diabetics, and healthy, physically inactive adults. 
Reductions in the current study are slightly lower than significant (p<0.05) decreases 
induced in combined exercise interventions ranging from to 16-weeks to 12-months, exercising 
two to three times per week (De Luca et al., 2016; Dieli-Conwright, Courneya, et al., 2018; 
Thomas et al., 2017). However, changes in the current study are similar to non-significant 
(p>0.05) results induced in combined interventions (0.0% to -10.7%), with programs ranging 
from 8-18 weeks, exercising two to three times per week (An et al., 2020; Battaglini et al., 
2007; Casla et al., 2015; De Backer et al., 2007; Herrero et al., 2006; Pinto et al., 2003). Body 
fat percentage results from the current study are higher than those associated with resistance 
interventions, with non-significant (p<0.05) changes (-0.3% to -1.2%) induced in interventions 
from 8-12 weeks, exercising once or twice per week (Santos et al., 2019; Schmitz et al., 2009). 
Aerobic interventions have been associated with non-significant (p>0.05) increases in body fat 




(3.7% and 6.9% respectively), while a 10-week, thrice weekly aerobic intervention found 
significant (p<0.05) decreases of 9.3% (An et al., 2020; Burnham & Wilcox, 2002). 
 While there were no statistical changes in body composition in the intervention or 
control group over time or between the groups, the HIFT group trended to a more favourable 
body composition of increased lean mass and decreased fat mass, while the control group 
trended in the direction of increasing fat mass and decreasing lean body mass. On average, the 
effects of the HIFT program were positive on body composition variables, suggesting that a 
HIFT program in already active breast cancer survivors does not provide detrimental effects 
on body composition. Due to the already physically active nature of the participants, the HIFT 
intervention may have more effect if participants were inactive. 
 Cardiorespiratory 
Low cardiorespiratory fitness is associated with a reduction in breast cancer and all-
cause mortality, as well as breast cancer recurrence (An et al., 2020; Kokkinos et al., 2010; 
Myers et al., 2002). Breast cancer survivors have higher blood pressure than healthy individuals 
(Jones et al., 2014). Higher blood pressure leads to a greater risk for CVD. Therefore, exercise 
interventions that can improve CRF and lower resting blood pressure provide significant 
benefits to not only breast cancer survivors, but also the general population. 
V̇O2peak 
There was no significant change in V̇O2peak over time in either group (p=.324), nor were 
there differences between groups throughout the intervention (p=.705), with changes of 0.7% 
and 3.5% in the HIFT and control groups. V̇O2peak changes from the current study are lower 
than those associated with HIFT, aerobic and combined exercise interventions. 
HIFT interventions in younger and inactive individuals have induced significant 
increases in V̇O2peak of 3.2% to 5.5%, in interventions ranging from six to eight weeks, 




effects of HIFT on in V̇O2peak in the current study are lower than significant results associated 
with other HIFT interventions, which may be attributed to the inactive nature and the younger 
age of the participants in previous studies compared to the current study. Cosgrove, Crawford, 
and Heinrich (2019) found non-significant increases in estimated V̇O2peak of 0.7% and 1.6% in 
males and females undertaking a 6-month CrossFit intervention exercising on average, 4 times 
per week. These lack of changes in V̇O2peak may be due to relatively high initial V̇O2peak (>42.0 
mL/kg/min), and the use of estimated V̇O2, a less valid measurement of CRF (Cosgrove et al., 
2019). 
Combined exercise interventions in breast cancer survivors have elicited significant 
increases in V̇O2peak/V̇O2max of 4.3% - 50.6%, with the exception of An et al. (2020), whose 
thrice weekly, 17-week intervention was associated with a significant reduction of 1.4%. 
Interventions ranged from 8 to 24 weeks, exercising once to thrice weekly (Casla et al., 2015; 
De Backer et al., 2007; De Luca et al., 2016; Dieli-Conwright, Courneya, et al., 2018; Dolan 
et al., 2018; Herrero et al., 2006; Kampshoff et al., 2015; Martin et al., 2015; Ortega & de Paz 
Fernández, 2016; Schulz et al., 2018). Average initial V̇O2max/peak of these studies were lower 
than the cohort in the current study, ranging from 21 to 27 mL/kg/min, with the exception of 
An et al. (2020) (28.4). Average post-test V̇O2peak/V̇O2max ranged from 22.9 to 35.1 mL/kg/min, 
compared to the current study’s 29.50 and 28.12 mL/kg/min pre-test and 29.72 and 29.10 
mL/kg/min post-test values for intervention and control groups respectively. 
Aerobic exercise interventions in breast cancer survivors have induced significant 
increases of 11.5% to 15.0%, and non-significant decreases of 1.7% to 2.1%. Intervention 
lengths ranged from 3- to 22-weeks, exercising one- to two-times weekly (An et al., 2020; 
Brdareski et al., 2012; Dolan et al., 2016). Aerobic interventions in those with lower initial 
V̇O2peak (>22 mL/kg/min) are associated with significant increases, while interventions in those 




insignificant decreases, suggesting it is harder to increase V̇O2peak in those already aerobically 
fit (An et al., 2020; Brdareski et al., 2012). Combined interventions are associated with the 
largest increases in V̇O2peak among breast cancer survivors (De Luca et al., 2016; Dieli-
Conwright, Courneya, et al., 2018; Kampshoff et al., 2015; Ortega & de Paz Fernández, 2016). 
However, significant increases have also been associated with both aerobic and functional 
interventions (Brdareski et al., 2012; Crawford et al., 2018; Dolan et al., 2016). 
While there were no significant improvements in V̇O2peak in either the HIFT or control 
group, participants were already physically active and had a relatively high level of baseline 
fitness compared to other interventions in breast cancer survivors (Casla et al., 2015; De Backer 
et al., 2007; De Luca et al., 2016; Dieli-Conwright, Courneya, et al., 2018; Dolan et al., 2018; 
Herrero et al., 2006; Kampshoff et al., 2015; Martin et al., 2015; Ortega & de Paz Fernández, 
2016; Schulz et al., 2018). In this context, the results of the current study suggest that HIFT 
can maintain aerobic fitness in already active breast cancer survivors. 
Blood pressure 
 There was a significant reduction in resting systolic blood pressure, with reductions of 
2.7% in the HIFT group and 12.5% in the control group (p=0.012). Reductions in the HIFT 
group are slightly lower than those associated with other studies, with functional and combined 
interventions inducing significant reductions of 3.6% and 9.2% respectively (Brisebois et al., 
2018; Lee et al., 2019). While lower than changes associated with other interventions, 
reductions in systolic blood pressure induced in the current study show that a HIFT intervention 
in breast cancer survivors can provide significant benefits to resting systolic blood pressure. 
 Neither group had significant changes in diastolic blood pressure, with reductions of 
1% and 7.3% in the HIFT and control groups respectively. Reductions in diastolic blood 
pressure in the HIFT group are lower than those induced in a HIFT intervention undertaken by 




pressure after a thrice weekly, eight week HIFT intervention. These reductions were seen in 
physically inactive adults, compared to the physically active participants in the current study, 
which may account for the variation in changes induced. Resting blood pressure measures were 
taken prior to the V̇O2max test, with apprehension for this test potentially increasing resting 
variables. 
Heart rate peak 
No significant (p>0.05) change in heart rate peak was induced in either group over the 
length of the intervention, with increases of 0.9% and 1.5% in the intervention and control 
groups respectively. Due to the linear relationship between heart rate and oxygen consumption, 
peak heart rate within 10 beats per minute of age predicted HRmax is often used as a criterion 
for determining whether participants achieved V̇O2max (Kenney et al., 2012; Lumb, 2010). In 
the pre-tests, eleven out of 20 participants achieved peak heart rate within 10bpm of age-
predicted HRmax, with this number rising to fourteen in the post-tests. Heart rate was predicted 
using the 208 – (.7 * age) formula (Tanaka et al., 2001). Other criteria used for establishing 
V̇O2peak included increases in V̇O2<150mL, respiratory quotient>1.1, no increase in heart rate 
with increased resistance, and RPE > 18. In the pre-test, 17 out of 20 (85%) participants attained 
at least three of the five criterion for V̇O2max, with this number rising to 19 (95%) in the post-
test, with the one remaining test stopped early due to the participant’s pregnancy. 
Strengths, limitations and future research 
Strengths 
 Maximal exercise testing is the gold standard for measuring V̇O2max; however, it is often 
difficult to use in clinical populations. The current study used a direct measure of V̇O2peak, 
while aiming to attain as many of the criterion for V̇O2max as possible. Maximal exercise testing 
provides less chance of over- or under-estimating individuals true maximal CRF, and can more 




 Exercise adherence to the HIFT intervention was exceptional, with all 16 participants 
completing all 40-sessions over a 20-week period. Participants exercised at a high intensity 
during the study, with an average exercise intensity of 83.7% HRmax. No adverse effects to the 
intervention were observed. Anecdotally, participants in the HIFT intervention found it 
enjoyable, with three main reasons standing out. One was the change from participants regular 
gym routine, with the higher-intensity and variation found to be very enjoyable. Secondly, 
some participants enjoyed the shorter exercise sessions, with the circuit lasting half an hour 
compared to the usual one hour combined exercise gym sessions participants undertook prior 
to the intervention. While some participants did not thoroughly enjoy working out, they 
understand the benefits that exercise can provide, and the ability to attain the same benefits in 
a shorter session was seen, in some, as very appealing. Finally, the group aspect of the circuit 
sessions was another main source of enjoyment for the participants 
 The duration of the intervention was a key strength of the study. Throughout the 
literature, a common theme among exercise interventions in breast cancer survivors is the need 
to investigate the effect of exercise interventions over a longer period of time. While there are 
some exceptions, exercise studies in breast cancer survivors tend to be around 8-16 weeks. The 
initial length of the study was 24-weeks, however due to unforeseen circumstances, the 
duration was shortened to 20-weeks.  
Limitations 
 The sample size of the current study was relatively small compared to other 
interventions, with only 16 participants completing the HIFT intervention, and 4 controls. The 
relatively small sample size was in part due to the small sample group of available participants, 
with the number of participants that chose to undertake the HIFT intervention, most, if not all 
of the women that both attended the ExPinkTTM clinic and met the criteria. This meant that 




the HIFT intervention or serve as controls. However, the high percentage of those who were 
available to undertake the intervention that chose to participate could suggest that had there 
been access to a larger population group, the number of participants would have increased. A 
greater number of participants may have increased the power of the study’s findings. 
 The current study had no randomisation, as researchers believed it was best to allow, in 
this instance, all that wanted to undertake the HIFT intervention the opportunity to participate. 
The intervention period was one of the strengths of the study; however, it was originally 
intended to be longer, which may have changed results. The level 4 lockdown to control 
COVID-19 in New Zealand at the time the study was to begin delayed the start. It is possible 
that a longer intervention period may have led to further increases in fitness variables observed. 
 Two sessions of HIFT a week has been shown to provide significant benefits to 
metabolic and cardiorespiratory systems, however due to the already physically active nature 
of the participants, the stimulus may have been insufficient (Feito et al., 2018). Bio-impedance 
analysis was used to measure body composition variables and, while acceptable, DXA scans 
would have provided more accurate measurements. 
Recommendations for future research 
While the length of the intervention was one of its strengths, there is even less research 
on the effect of exercise longer than 24-weeks, and future research could investigate even 
longer interventions. Future research may also investigate the effects of a larger training 
volume over the same time period, for example, thrice weekly HIFT sessions. 
There remains a gap in the research in investigating the effect of functional training, 
whether high-intensity or not, in older breast cancer survivors. Participants in the current study 
were relatively young (37-62 years old), and investigating the effect functional training could 





Future research may choose to investigate other variables, such as submaximal aerobic 
fitness, muscular endurance or using qualitative analysis. Research involving the use of surveys 
or interviews could investigate the experiences of participants undertaking the intervention, 
rather than solely observing the quantitative changes seen in overserved physiological and 
functional variables. 
While maximal aerobic fitness showed no significant increase, there may have been 
improvements in participants submaximal aerobic fitness. Analysis of participants respiratory 
thresholds may provide an insight into submaximal fitness changes. HIFT participants in the 
current study exercised at a high intensity, averaging 83.7% HRmax during the circuits, and 
other studies may choose to investigate the effect of higher or lower intensities on muscle 
strength, CRF and body composition variables, having participants exercise at specific 
intensities for aerobic and/or strength increases. 
Muscular endurance can be measured through maximal repetition tests (number of 
bench press reps, number of leg press reps) at a given weight and can give an indication to the 
muscular endurance of an individual. Muscular endurance tests would provide further insight 
into the effect of the HIFT intervention on functional capacity. 
In future studies, dietary information may want to be collected to enable researchers to 
determine whether changes in body weight were due to the exercise intervention or dietary 
changes. Similarly, future research could investigate the effect that combining a HIFT program 
with a dietary intervention on body composition variables in breast cancer survivors. 
With larger sample sizes, researchers could increase the power of the study to detect 
between group differences and reduce or eliminate bias and confounding variables such as 






 To conclude, the results from the current study show that a 20-week HIFT intervention 
can provide improvements in functional and lower body strength, as well as maintaining body 
composition, upper body strength and cardiorespiratory variables in already physically active 
breast cancer survivors. Functional carry tests and lower body strength increased in response 
to the HIFT intervention, similar to changes in controls completing their regular exercise 
routines. Improvements in functional fitness and muscle strength can improve capacity for 
ADLs and quality of life. While no changes were induced in body composition or 
cardiorespiratory fitness, the already physically active nature of the participants may have 
prevented further improvements. Higher CRF can reduce the risk of breast cancer and all-cause 
mortality, and while the current intervention was not associated with any improvements in 
CRF, initial fitness levels of participants were already high. Further research into HIFT training 
is needed, particularly to assess its ability to be undertaken in less active breast cancer 
populations. Findings from the present study are that a HIFT intervention can effective at 
improving or maintaining levels of functional fitness, CRF, muscle strength and body 
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Appendix C: Exercise programs 
HIFT Exercises  
Program – First 5 weeks 
Combinations 
1. 150m row + 8 dumbbell push presses 
2. 10 kettlebell swings + 10 air squats 
3. 8 machine bench presses + 10 high knees 
4. 5 burpees + 5 dumbbell thrusters + 10 medicine ball twists 
5. 10 lat pulldowns + 10 mountain climbers 
6. 8 kettlebell deadlifts + 20 skips 
7. 10 renegade rows + 10 dead bugs (alternate arm and leg) 
8. 10 Bosu ball biceps curls + 4-point lunges (6 each point) 
Single modality 
1. Cycling 2 minutes high intensity 
2. Treadmill walk or run high intensity – 2 minutes 
3. Cross trainer 2 minutes high intensity 
4. Rowing 2 minutes high intensity  
Program 2 – Second 5 weeks 
Combinations 
1. 10 steps with dumbbells + 30s plank 
2. 10 butt kicks + 10 pushups 
3. 10 seated dumbbell presses + 10 medicine ball slams 
4. 10 cable rows + 10 lat pulldowns 
5. 10 Single arm kettlebell or dumbbell floor press (5 each side) + 10 single leg 
glute bridges (10 each side) 
6. 12 lying toe touches + 20 Russian twists with dumbbell or kettlebell – feet 
elevated 
7. 30s skipping + 10 lunges with bicep curl – alternate legs 
8. 10 lying hamstring curls + 10 Romanian deadlifts (knees slightly bent) 
Single modality 
1. Cycling 2 minutes high intensity 
2. Treadmill walk or run high intensity – 2 minutes 
3. Arm grinder – 2 minutes high intensity 
4. Rowing 2 minutes high intensity  
Program 3 – Third 5 weeks 
Combinations 
1. 10 jumping jacks + 10 goblet squats with kettlebell 




3. 10 reverse lunges with single arm DB press (alternate opposite arm with leg) 
+ 20 skips 
4. 10 machine rows + 10 KB single arm deadlifts 
5. 8 stand to kneel + 10 KB figure of 8 
6. 10 Spiderman planks + 20 crunches 
7. 10 bungy tricep pushdowns + 100m row 
8. 10 side step ups + 10 Renegade rows 
Single modality 
5. Cycling 2 minutes high intensity 
6. Treadmill walk or run high intensity – 2 minutes 
7. 2 minutes super skaters 
8. 2 skipping  
Program 4 – Fourth 5 weeks 
Combinations 
1. 4 Suicide jumps, squat to touch floor (either a jump or step back) + 10 spider 
climbers from middle marker 
2. 10 serratus anterior pulldowns + 10 TheraBand upright rows + 10 inchworm 
toe touches  
3. 10 (each arm) single arm kettlebell swings + 10 medicine ball slams 
4. 10 dumbbell sit-up to press + 10 dumbbell tricep extensions 
5. 5 (each side) curtsy lunges + 10 Swiss ball leg curls 
6. 10 dumbbell Zottman curls + 20 calf raises (holding dumbbells) 
7. 5 burpees + 10 kettlebell plank drags 
8. 10 Bulgarian squats (5 each leg) – or split squats + 10 dumbbell/kettlebell 
pullovers 
Single modality 
1. Cycling 2 minutes high intensity 
2. Treadmill walk or run high intensity – 2 minutes 
3. 2 minutes rowing 
4. X-trainer – 2 minutes  
 
 
